DRAMP_ID	Sequence	Sequence_Length	Name	Source	Activity	Patent_No	Patent_Type	Publication_Date	Also_Publication_As	Patent_Title	Abstract
DRAMP04719	VNPGVVVRISQKGLDYASQQGTAALQXXLKHIKIPDYL	38	Sequence 3 from Patent EP 0272489	Synthetic construct	Antimicrobial	EP 0272489 B1	Granted Patent	1996##3##13	"DE3751741D1, DE3751741T2, EP0272489A2, EP0272489A3, US5126257"	"Antimicrobial proteins, compositions containing same and uses thereof."	"Further provided are purified polypeptides useful as antimicrobial agents, and methods for producing these polypeptides."
DRAMP04720	IIGGRESRPHSRPYMAYLQIQXPA	24	Sequence 4 from Patent EP 0272489	Synthetic construct	Antimicrobial	EP 0272489 B1	Granted Patent	1996##3##13	"DE3751741D1, DE3751741T2, EP0272489A2, EP0272489A3, US5126257"	"Antimicrobial proteins, compositions containing same and uses thereof."	"Further provided are purified polypeptides useful as antimicrobial agents, and methods for producing these polypeptides."
DRAMP04721	KVFERXELARTLKRL	15	Sequence 5 from Patent EP 0272489	Synthetic construct	Antimicrobial	EP 0272489 B1	Granted Patent	1996##3##13	"DE3751741D1, DE3751741T2, EP0272489A2, EP0272489A3, US5126257"	"Antimicrobial proteins, compositions containing same and uses thereof."	"Further provided are purified polypeptides useful as antimicrobial agents, and methods for producing these polypeptides."
DRAMP04722	VNPGVVVRISQKGLDYASQQGTAALQXXLKNIKIPDYL	38	Sequence 6 from Patent EP 0272489	Synthetic construct	Antimicrobial	EP 0272489 B1	Granted Patent	1996##3##13	"DE3751741D1, DE3751741T2, EP0272489A2, EP0272489A3, US5126257"	"Antimicrobial proteins, compositions containing same and uses thereof."	"Further provided are purified polypeptides useful as antimicrobial agents, and methods for producing these polypeptides."
DRAMP04723	TCRYLLVRSLQTFSQAXFTXRRXYRGNLVSINNFNINYRI	40	Sequence 7 from Patent EP 0272489	Synthetic construct	Antimicrobial	EP 0272489 B1	Granted Patent	1996##3##13	"DE3751741D1, DE3751741T2, EP0272489A2, EP0272489A3, US5126257"	"Antimicrobial proteins, compositions containing same and uses thereof."	"Further provided are purified polypeptides useful as antimicrobial agents, and methods for producing these polypeptides."
DRAMP04724	KNLRRXXRKXXHIIKKYG	18	Sequence 1 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04725	KNLRRIIRKIIHIIKKYG	18	Sequence 2 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04726	KNLRRGIRKIIHIIKKYG	18	Sequence 3 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04727	KNLRRTIRKIIHIIKKYG	18	Sequence 4 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04728	KNLRRSIRKIIHIIKKYG	18	Sequence 5 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04729	KNLRREIRKIIHIIKKYG	18	Sequence 6 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04730	KNLRRDIRKIIHIIKKYG	18	Sequence 7 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04731	KNLRRAIRKIIHIIKKYG	18	Sequence 8 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04732	KNLRRIGRKIIHIIKKYG	18	Sequence 10 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04733	KNLRRITRKIIHIIKKYG	18	Sequence 11 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04734	KNLRRISRKIIHIIKKYG	18	Sequence 12 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04735	KNLRRIERKIIHIIKKYG	18	Sequence 13 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04736	KNLRRIDRKIIHIIKKYG	18	Sequence 14 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04737	KNLRRIARKIIHIIKKYG	18	Sequence 15 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04738	KNLRRIIRKGIHIIKKYG	18	Sequence 17 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04739	KNLRRIIRKTIHIIKKYG	18	Sequence 18 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04740	KNLRRIIRKSIHIIKKYG	18	Sequence 19 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04741	KNLRRIIRKEIHIIKKYG	18	Sequence 20 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04742	KNLRRIIRKDIHIIKKYG	18	Sequence 21 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04743	KNLRRIIRKAIHIIKKYG	18	Sequence 22 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04744	KNLRRIIRKIGHIIKKYG	18	Sequence 24 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04745	KNLRRIIRKITHIIKKYG	18	Sequence 25 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04746	KNLRRIIRKISHIIKKYG	18	Sequence 26 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04747	KNLRRIIRKIEHIIKKYG	18	Sequence 27 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04748	KNLRRIIRKIDHIIKKYG	18	Sequence 28 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04749	KNLRRIIRKIAHIIKKYG	18	Sequence 29 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04750	KNLRRIIRKGIRIIKKYG	18	Sequence 32 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04751	KRLRRIIRKGIHIIKKYG	18	Sequence 34 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04752	RRLRRIIRKGIRIIKKYG	18	Sequence 36 from Patent US 20020082195	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0082195 A1	Patent Application	2002##6##27	"CN1735422A, US6492328"	Novispirins: antimicrobial peptides.	"Novispirin peptides are antimicrobial agents with potent activity against Gram-negative bacteria. The peptides are nonhemolytic, exhibit reduced in vitro cytotoxicity relative to other antimicrobial peptides, and were well-tolerated in vivo after intravenous injection. Novispirins also bind lipopolysaccharide (LPS), a property that may mitigate symptoms associated with Gram-negative bacterial infection. A pharmaceutical composition comprising novispirin as an active agent is administered to a patient suffering from or predisposed to a microbial infection, particularly Gram-negative bacterial infections."
DRAMP04753	MRIHYLLFALLFLFLVPVPGHGGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK	67	Sequence 2 from Patent US 20020115602	Synthetic construct	Antimicrobial	US 2002/0115602 A1	Patent Application	2002##8##22	"US6809181, WO2001092309A2, WO2001092309A3"	"Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide."	"The present invention relates a novel antimicrobial peptide HBD-3 and derivatives thereof as well as the gene encoding the peptide. The invention further relates to methods of use of the HBD-3 peptide including a method of inhibiting microbial growth by administering an effective amount of the HBD-3 peptide alone or in combinination with other antimicrobial agents or antibiotics. In addition, the immunomodulatory properties of the HBD-3 peptide also facilitate the manipulation of the immune response, i.e., as a chemoattractant for immature dentritic cells or memory T cells."
DRAMP04754	TLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK	41	Sequence 3 from Patent US 20020115602	Synthetic construct	Antimicrobial	US 2002/0115602 A1	Patent Application	2002##8##22	"US6809181, WO2001092309A2, WO2001092309A3"	"Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide."	"The present invention relates a novel antimicrobial peptide HBD-3 and derivatives thereof as well as the gene encoding the peptide. The invention further relates to methods of use of the HBD-3 peptide including a method of inhibiting microbial growth by administering an effective amount of the HBD-3 peptide alone or in combinination with other antimicrobial agents or antibiotics. In addition, the immunomodulatory properties of the HBD-3 peptide also facilitate the manipulation of the immune response, i.e., as a chemoattractant for immature dentritic cells or memory T cells."
DRAMP04755	GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK	45	Sequence 4 from Patent US 20020115602	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0115602 A1	Patent Application	2002##8##22	"US6809181, WO2001092309A2, WO2001092309A3"	"Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide."	"The present invention relates a novel antimicrobial peptide HBD-3 and derivatives thereof as well as the gene encoding the peptide. The invention further relates to methods of use of the HBD-3 peptide including a method of inhibiting microbial growth by administering an effective amount of the HBD-3 peptide alone or in combinination with other antimicrobial agents or antibiotics. In addition, the immunomodulatory properties of the HBD-3 peptide also facilitate the manipulation of the immune response, i.e., as a chemoattractant for immature dentritic cells or memory T cells."
DRAMP04756	WCFAVCRRGRCRYKCRR	17	Sequence 1 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04757	WCFAVCYRGRCRRKCRR	17	Sequence 2 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04758	FRWCFRVCYKGRCRYKCR	18	Sequence 3 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04759	RRWCFRVCYKGFCRYKCR	18	Sequence 4 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04760	RRWCFRVCYRGFCRYFCR	18	Sequence 5 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04761	RRWCFIVCRRGACYRRCR	18	Sequence 6 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04762	RRWCFIVCRRGRCYVACRR	19	Sequence 7 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04763	RVWCRRRCYRGFCRYFCR	18	Sequence 8 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04764	RVWCRYRCYRGFCRRFCR	18	Sequence 9 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04765	RRWCRRVCYAGFCYRKCR	18	Sequence 10 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04766	RRWCFRVCYRGRFCYRKCR	19	Sequence 11 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04767	KWCFRVCYRGICYRRCR	17	Sequence 12 from Patent US 20020156017	Tachypleus tridentatus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04768	RRWCFRVCYRGFCYRKCR	18	Sequence 13 from Patent US 20020156017	Limulus polyphemus	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04769	WCFXVCXRGXCRXKCRR	17	Sequence 14 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04770	XRWCFRVCYXGXCXXXCR	18	Sequence 15 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04771	RRWCFXVCXRGXCYXXCRX	19	Sequence 16 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04772	RXWCXXXCYRGFCXXXCR	18	Sequence 17 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04773	RRWCXRVCYXGFCYRKCR	18	Sequence 18 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04774	RRWCFRVCYRGXFCYRKCR	19	Sequence 19 from Patent US 20020156017	Synthetic construct	"Antimicrobial, Antibacterial, Antifungal"	US 2002/0156017 A1	Patent Application	2002##10##24	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Antimicrobial peptides and methods of use thereof.	"A class of cationic, polyphemusin-like peptides having antimicrobial activity is provided. Examples of such peptides include FRWCFRVCYKGRCRYKCR (SEQ ID NO: 3), RRWCFRVCYKGFCRYKCR (SEQ ID NO: 4), and RRWCFRVCYRGRFCYRKCR (SEQ ID NO: 11). Also provided are methods for inhibiting the growth of microbes such as bacteria, yeast and viruses utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject."
DRAMP04775	GIGKFLKSAKKFGKAFVKILNS	22	Sequence 3 from Patent US 20020162135	Synthetic construct	Antimicrobial	US 2002/0162135 A1	Patent Application	2002##10##31	"CA2412531A1, CA2412531C, EP1294745A2, US6337317, US6747007, WO2002000687A2, WO2002000687A3, WO2002000687A9"	Expression of antimicrobial peptide via the plastid genome to control phytopathogenic bacteria.	This invention provides a novel method to confer disease resistance to plants. Plant plastids are transformed using a plastid vector which contains heterologous DNA sequences coding for a cytotoxic antimicrobial peptide. Transgenic plants are capable of fighting off phytopathogenic bacterial infection.
DRAMP04776	RQRDPQQQAEQAQKRAQRRETE	22	Sequence 9 from Patent US 20020168392	Synthetic construct	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04777	PRHMQIAQQRAERRAEKEKRKQQKR	25	Sequence 10 from Patent US 20020168392	Synthetic construct	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04778	SEQIDNMAWFHVSVCNAVFVVIIIIMLLMFVPVVRG	36	Sequence 11 from Patent US 20020168392	Synthetic construct	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04779	MGHHHHHHHHHHSSGHIEGRHM	22	Sequence 16 from Patent US 20020168392	Synthetic construct	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04780	RSGRGECRRQCLRRHEGQPWETQECMRRCRRRG	33	Sequence 23 from Patent US 20020168392	Maize	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04781	VKEDHQFETRGEILECYRLCQQQ	23	Sequence 26 from Patent US 20020168392	Stenocarpus sinuatus	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04782	QKHRSQILGCYLXCQQL	17	Sequence 27 from Patent US 20020168392	Stenocarpus sinuatus	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04783	LDPIRQQQLCQMRCQQQEKDPRQQQQCK	28	Sequence 28 from Patent US 20020168392	Stenocarpus sinuatus	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04784	MAWFHVSVCNAVFVVIIIIMLLMFVPVVRGRQRDPQQQYEQCQKRCQRRETEPRHMQICQQRCERRYEKEKRKQQKR	77	Sequence 30 from Patent US 20020168392	Synthetic construct	Antimicrobial	US 2002/0168392 A1	Patent Application	2002##11##14	"CA2274730A1, CN1244769A, DE69736904D1, DE69736904T2, EP1006785A1, EP1006785A4, EP1006785B1, US7067624, US20030171274, WO1998027805A1"	Antimicrobial proteins.	A new family of antimicrobial proteins is described. Prototype proteins can be isolated from Macadaniia integrifolia as well as other plant species. DNA encoding the protein is also described as well as DNA constructs which can be used to express the antimicrobial protein or to introduce the antimicrobial protein into a plant. Compositions comprising the antimicrobial proteins or the antimicrobial protein per se can be administered to plants or mammilian animals to combat microbial infestation.
DRAMP04785	RVIRVVQRACRAIRHIVRRIRQGLRRIL	28	Sequence 1 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04786	RVIRVVQRACRAIRHIVRRIRQGLRRILRVV	31	Sequence 2 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04787	RWIRVVQRWCRAIRHIWRRIRQGLRRWLRVV	31	Sequence 3 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04788	RVVRVVRRVVRR	12	Sequence 4 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04789	RRVVRRVRRVVRRVVRVVRRVVRR	24	Sequence 5 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04790	VRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR	36	Sequence 6 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04791	RRVVRRVRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR	42	Sequence 7 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04792	RVVRVVRRVVRRVRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR	48	Sequence 8 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04793	RVVRVVRRWVRR	12	Sequence 9 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04794	RRWVRRVRRVWRRVVRVVRRWVRR	24	Sequence 10 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04795	VRRVWRRVVRVVRRWVRRVRRVWRRVVRVVRRWVRR	36	Sequence 11 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04796	RVVRVVRRWVRRVRRVWRRVVRVVRRWVRRVRRVWRRVVRVVRRWRVV	48	Sequence 12 from Patent US 20020169279	Synthetic construct	"Antimicrobial, Antibacterial"	US 2002/0169279 A1	Patent Application	2002##11##14	US6835713	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04797	RVVRVVRRWVRRVRRVWRRVVRVVRRWVRRVRRVWRRVVRVVRRWVRR	48	Sequence 12 from Patent US 6835713	Synthetic construct	"Antimicrobial, Antibacterial"	US 6835713 B2	Granted Patent	2004##12##28	US20020169279	Virus derived antimicrobial peptides.	"The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo."
DRAMP04798	MAVMKSRTVIVAAVLLAVVILSSLCPCYEAGGCTIGKPPKTPAPKRPCFSPYSEDHCDRQNCRFVCMSHGYSDGGWCDEREVRKMCCCYH	90	Sequence 2 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04799	MAVMKSRTVIVAAVLLAVVILSSLCPCYEAGGCIGKPPKTPAPKRPCFSPYSEDHCDRQNCRFVCMSHGYSDGGWCDEREVRKMCCCYH	89	Sequence 6 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04800	MMALNGGWRKTFVSILTTCFLVVVVIVSLSCEAKGGVVPRLRPPFCFPYDREYCTPFHCGKVCQEYNFPAKNGGYCDKRGDPWKCCCPY	89	Sequence 10 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04801	MAKFFNYTIVQGLLMLSMVLLASCVIHAHIISGETEEVSNIGSPTVMVTMGANRKIIGDNKNLLCYLKALEYCCERTKQCYDDIKKCLEHCHG	93	Sequence 14 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04802	MMTKCQKRASIQGLWLLSMVLLASSSLVCASMAVDGQTKEDINATSVTSMNMTRSSSASYNMTGGGGELNRGPCVVRSGFYWCQNIGYPTMSECLKNCES	100	Sequence 18 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04803	MARCLKSCSVHGLWLLSMILLASCVVHAHIINGRQSNTGSLTMTTTGEASMIIGDEKDAICYIKAALYCCKRTIQCYQDIAQCLRNCRKNV	91	Sequence 22 from Patent US 20030028921	Zea mays	Antimicrobial	US 2003/0028921 A1	Patent Application	2003##2##6	US20130052682	Maize basal layer antimicrobial protein polynucleotides and method of use.	"Methods and compositions for modulating development and defense response are provided. Nucleotide sequences encoding maize BTL proteins are provided. The sequence can be used in expression cassettes for antimicrobial resistance, modulating development, developmental pathways, and defense response. Transformed plants, plant cells, tissues, and seed are also provided."
DRAMP04804	MIVGHGIDI	9	Sequence 6 from Patent US 20030068802	Streptococcus pneumoniae	Antimicrobial	US 2003/0068802 A1	Patent Application	2003##4##10	Unknown	"Use of streptococcus pneumoniae acyl carrier protein synthase crystal structure in diagnostics, antimicrobial drug design, and biosensors."	"Provided are methods of purifying and crystallizing Streptococcus pneumoniae acyl carrier protein synthase (AcpS) enzyme, crystals of AcpS, the use of such crystals to determine the three-dimensional structure of AcpS enzymes, and the three-dimensional structure of AcpS. The three-dimensional crystal structure of AcpS can be used in medical diagnostics to produce antibodies that permit detection of Streptococcus pneumoniae both in vitro and in vivo. The three-dimensional crystal structure of AcpS can also be used in pharmaceutical discovery and development to identify and design compounds that inhibit the biochemical activity of AcpS enzyme in bacteria. Inhibitory compounds identified in this way can be optimized by structure/activity studies to develop antibacterial pharmaceutical compounds useful for the prevention or treatment of bacterial infections."
DRAMP04805	FIHHIFRGIVHAGRSIGRFLTG	22	Sequence 1 from Patent US 20030083247	Morone saxitilis x Morone	Antimicrobial	US 2003/0083247 A1	Patent Application	2003##5##1	US6753407	Antimicrobial peptides isolated from fish.	"Antimicrobial peptides (endobiotic peptides), isolated from fish are described. Such endobiotic peptides may be isolated as 22 amino acid peptides having molecular weights of about 2500 Da from the gills of hybrid striped bass (Morone saxitilis¡ÁMorone chrysops). Antibodies that bind such peptides and methods of using such peptides are also described."
DRAMP04806	FFHHIFRGIVHVGKTIHRLVTG	22	Sequence 2 from Patent US 20030083247	Morone saxitilis x Morone	Antimicrobial	US 2003/0083247 A1	Patent Application	2003##5##1	US6753407	Antimicrobial peptides isolated from fish.	"Antimicrobial peptides (endobiotic peptides), isolated from fish are described. Such endobiotic peptides may be isolated as 22 amino acid peptides having molecular weights of about 2500 Da from the gills of hybrid striped bass (Morone saxitilis¡ÁMorone chrysops). Antibodies that bind such peptides and methods of using such peptides are also described."
DRAMP04807	FFHHIFRGIVHVGKTIHKLVTG	22	Sequence 3 from Patent US 20030083247	Morone saxitilis x Morone	Antimicrobial	US 2003/0083247 A1	Patent Application	2003##5##1	US6753407	Antimicrobial peptides isolated from fish.	"Antimicrobial peptides (endobiotic peptides), isolated from fish are described. Such endobiotic peptides may be isolated as 22 amino acid peptides having molecular weights of about 2500 Da from the gills of hybrid striped bass (Morone saxitilis¡ÁMorone chrysops). Antibodies that bind such peptides and methods of using such peptides are also described."
DRAMP04808	FFRHLFRGAKAIFRGARQGXRAHKVVSRYRNRDVPETDNNQEEP	44	Sequence 4 from Patent US 20030083247	Morone saxitilis x Morone	Antimicrobial	US 2003/0083247 A1	Patent Application	2003##5##1	US6753407	Antimicrobial peptides isolated from fish.	"Antimicrobial peptides (endobiotic peptides), isolated from fish are described. Such endobiotic peptides may be isolated as 22 amino acid peptides having molecular weights of about 2500 Da from the gills of hybrid striped bass (Morone saxitilis¡ÁMorone chrysops). Antibodies that bind such peptides and methods of using such peptides are also described."
DRAMP04809	HIFR	4	Sequence 5 from Patent US 20030083247	Synthetic construct	Antimicrobial	US 2003/0083247 A1	Patent Application	2003##5##1	US6753407	Antimicrobial peptides isolated from fish.	"Antimicrobial peptides (endobiotic peptides), isolated from fish are described. Such endobiotic peptides may be isolated as 22 amino acid peptides having molecular weights of about 2500 Da from the gills of hybrid striped bass (Morone saxitilis¡ÁMorone chrysops). Antibodies that bind such peptides and methods of using such peptides are also described."
DRAMP04810	GIGKFLHSAGKFGKAFVGEIMKS	23	Sequence 1 from Patent US 20030092612	Xenopus laevis	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04811	GIGKFLHSAKKFGKAFVGEIMNS	23	Sequence 2 from Patent US 20030092612	Xenopus laevis	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04812	GIGKFLKKAKKFGKAFVKILKX	22	Sequence 3 from Patent US 20030092612	Synthetic construct	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04813	GIGKFLKKAKKFGKAFVKILKK	22	Sequence 4 from Patent US 20030092612	Synthetic construct	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04814	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	37	Sequence 5 from Patent US 20030092612	Silk moth	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04815	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG	36	Sequence 6 from Patent US 20030092612	Silk moth	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04816	MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG	38	Sequence 7 from Patent US 20030092612	Synthetic construct	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04817	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	30	Sequence 8 from Patent US 20030092612	Human	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04818	CYCRIPACIAGERRYGTCIYQGRLWAFCC	29	Sequence 9 from Patent US 20030092612	Human	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04819	DCYCRIPACIAGERRYGTCIYQGRLWAFCC	30	Sequence 10 from Patent US 20030092612	Human	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04820	VVCACRRALCLPRERRAGFCRIRGRIHPLCCRR	33	Sequence 11 from Patent US 20030092612	Rabbit	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04821	RLCRVVIRVCR	11	Sequence 12 from Patent US 20030092612	Cow	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04822	KWKLFKKIGIGAVLKVLTTGLPALIX	26	Sequence 13 from Patent US 20030092612	Synthetic construct	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04823	KWKGIGAVLKVLTTGX	16	Sequence 14 from Patent US 20030092612	Synthetic construct	Antimicrobial	US 2003/0092612 A1	Patent Application	2003##5##15	"CA2451469A1, EP1406647A1, EP1406647A4, US6872705, WO2003006046A1"	"Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions."	"Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
DRAMP04824	KWKLFKKIGIGAVLKVLTTGLPALKLTK	28	Sequence 1 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04825	KWKSFIKKLTTAVKKVLTTGLPALIS	26	Sequence 2 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04826	KWKSFIKKLTSAAKKVVTTAKPLALIS	27	Sequence 3 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04827	KWKSFIKKLTKAAKKVVTTAKKPLIV	26	Sequence 4 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04828	KWKKFIKSLTKSAAKTVVKTAKKPLIV	27	Sequence 5 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04829	KWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK	32	Sequence 6 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04830	KLFKKIGIGAVLKVLKVLTTGLPALKLTLK	30	Sequence 7 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04831	KWKFKKIGIGAVLKVLKVLTTGLPALKLTLK	31	Sequence 8 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04832	KLWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK	33	Sequence 9 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04833	KWKSFIKKLTSAAKKVTTAAKPLTK	25	Sequence 10 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04834	KWKKFIKKIGIGAVLKVLTTGLPALKLTKK	30	Sequence 11 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04835	KKWKKFIKKIGIGAVLTTPGAKK	23	Sequence 12 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04836	GWGSFFKKAAHVGKHVGKAALTHYL	25	Sequence 13 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04837	KGWGSFFKKAAHVGKHVGKAALTHYL	26	Sequence 15 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04838	ALWKTMLKKAAHVGKHVGKAALTHYL	26	Sequence 17 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04839	SIGSAFKKAAHVGKHVGKAALTHYL	25	Sequence 18 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04840	GWGSFFKKAAHVGKHVGKAALGAAARRRK	29	Sequence 19 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04841	ALWKTMLKKAAHVGKHVGKAALGAAARRRK	30	Sequence 20 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04842	SIGSAFKKAAHVGKHVGKAALGAAARRRK	29	Sequence 21 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04843	RQRVEELSKFSKKGAAARRRK	21	Sequence 22 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04844	ALWKTMLKKLGTMALHAGKAALGAAADTISQTQ	33	Sequence 23 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04845	SIGSAFKKALPVAKKIGKAALPIAKAALP	29	Sequence 24 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04846	KWKSFIKKLTSAAKKVVTTAKPLISS	26	Sequence 25 from Patent US 20030096949	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0096949 A1	Patent Application	2003##5##22	"CA2341340A1, CA2341340C, EP1107976A1, EP1107976A4, US6288212, US6818407, WO2000012528A1"	Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.	"A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."
DRAMP04847	HVIGRFIHHFFCCFFHHIFRGIVH	24	Sequence 6 from Patent US 20030105281	Synthetic construct	Antimicrobial	US 2003/0105281 A1	Patent Application	2003##6##5	"WO2002014345A2, WO2002014345A3, WO2002014346A2, WO2002014346A8"	Antimicrobial peptides isolated from mast cells.	"Antimicrobial peptides (endobiotic peptides) isolated from mast cells are described, along with compositions containing the same and methods of use thereof. Such peptides obtained from fish mast cells are referred to as ""piscidins"" herein."
DRAMP04848	KWKSFIKNLTKGGSKILTTGLPALIS	26	Sequence 3 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04849	KWKKFIKNLTKGGSKILTTGLPALIS	26	Sequence 4 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04850	KWKSFIKNLEKVLKPGGLLSNIVTSL	26	Sequence 5 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04851	KWKSFIKNLEKVLKKGPILANLVSIV	26	Sequence 6 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04852	KWKEFIKKLTTAVKKVLTTGLPALIS	26	Sequence 7 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04853	KWKKFIKELQKVLAPGGLLSNIVTSL	26	Sequence 8 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04854	KWKSFIKKLTSVLKKVVTTALPALIS	26	Sequence 9 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04855	KWKSFIKNLTKVLKKVVTTALPALIS	26	Sequence 10 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04856	KWKLFKKKGTGAVLTVLTTGLPALIS	26	Sequence 11 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04857	KWKSFIKKLTSVLKKVVTTAKPLISS	26	Sequence 12 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04858	KKKSFIKLLTSAKVSVLTTAKPLISS	26	Sequence 13 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04859	KWKKFIKELQKVLKPGGLLSNIVTSL	26	Sequence 14 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04860	KKWWRRVLSGLKTGPALSNV	20	Sequence 15 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04861	KKWWRRVLKGLSSGPALSNV	20	Sequence 16 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04862	KKWWRRALQALKNGPALSNV	20	Sequence 17 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04863	KKWWRRVLSGLKTAGPAIQSVLNK	24	Sequence 18 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04864	KKWWRRALQGLKTAGPAIQSVLNK	24	Sequence 19 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04865	KKWWKAQKAVNSGPNALQTLAQ	22	Sequence 20 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04866	KKWWKAKKFANSGPNALQTLAQ	22	Sequence 21 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04867	KKWWKFIKKAVNSGTTGLQTLAS	23	Sequence 22 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04868	KKSFFKKLTSVASSVLS	17	Sequence 23 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04869	WKVFKSFIKKASSFAQSVLD	20	Sequence 24 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04870	KWKSFIKK	8	Sequence 34 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04871	KKWWRRXXXGLKTAGPAIQSVLNK	24	Sequence 35 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04872	KWKLFKKIGIGAVLKVLTTGLPALIS	26	Sequence 36 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04873	KWKLFKKIGIGAVLKVLTTGLPALKKTK	28	Sequence 37 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04874	KKWWRRXLXXLXXXGPAXXSXVXXX	25	Sequence 38 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04875	KKWWKXXXKXXNSGXXXLQTLAX	23	Sequence 39 from Patent US 20030176337	Synthetic construct	"Antimicrobial, Antibacterial"	US 2003/0176337 A1	Patent Application	2003##9##18	"US6057291, US6297215, US6465429, US6906035, WO1998025953A1"	Antimicrobial cationic peptides.	A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO: 1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO: 2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.
DRAMP04876	YNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK	34	Sequence 1 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04877	YKCLQHGGFCLRSSCPSNTKLQGTCKPDKPNCCKS	35	Sequence 2 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04878	TRCYKFGGFCHYNICPGNSRFMSNCHPENLRCCKN	35	Sequence 3 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04879	ARCYKFGGFCYNSMCPPHTKFIGNCHPDHLHCCIN	35	Sequence 4 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04880	DHCHTNGGYCVRAICPPSARRPGSCFPEKNPCCKY	35	Sequence 5 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04881	ERCHKKGGYCYFYCFSSHKKIGSCFPEWPRCCKN	34	Sequence 6 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04882	YYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRR	35	Sequence 7 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04883	FFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRK	35	Sequence 8 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04884	VSCIRNGGICQYRCIGLRHKIGTCGSPFKCCK	32	Sequence 9 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04885	VSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKR	34	Sequence 10 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04886	RACYREGGECLRCIGLFHKIGTCNFRFKCCKF	32	Sequence 11 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04887	ITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKI	34	Sequence 12 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04888	VTCMSYGGSCQRSCNGSFRLGGHCGHPKIRCCRR	34	Sequence 13 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04889	VSCCMIGGICRYLCKGNILQNGNCGVTSLNCCKR	34	Sequence 14 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04890	VTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKK	35	Sequence 15 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04891	GHCLNLSGVCRRDVCKVVEDQIGACRRRMKCCRA	34	Sequence 16 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04892	KQCIALKGVCRDKLCSTLDDTIGICNEGKKCCRR	34	Sequence 18 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04893	KQCISLKGICKDLACT	16	Sequence 19 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04894	KKCVQRKNACHYFECPWLYYSVGTCYKGKGKCCQK	35	Sequence 20 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04895	IKCLQGNNNCHIQKCPWFLLQVSTCYKGKGRCCQK	35	Sequence 21 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04896	IQCFQKNNTCHTNQCPYFQDEIGTCYDKRGKCCQK	35	Sequence 22 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04897	IACIENKDTCRLKNCPRLHNVVGTCYEGKGKCCHK	35	Sequence 23 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04898	TICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVS	35	Sequence 24 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04899	TVCLMQQGHCRLFMCRSGERKGDICSDPWNRCCVP	35	Sequence 25 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04900	DECPSEYYHCRLKCNADEHAIRYCADFSICCKL	33	Sequence 26 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04901	QDCSKHRHCRMKCKANEYAVRYCEDWTICCRV	32	Sequence 27 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04902	KKCLNDVGICKKKCKPEEMHVKNGWAMCGKQRDCCVP	37	Sequence 28 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04903	KKCANTLGNCRKMCRDGEKQTEPATSKCPIGKLCCVL	37	Sequence 29 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04904	RRCLMGLGRCRDHCNVDEKEIQKCKMKKCCVG	32	Sequence 30 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04905	KRCLVGFGKCKDSCLADETQMQHCKAKKCCIG	32	Sequence 31 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04906	RRCYYGTGRCRKSCKEIERKKEKCGEKHICCVP	33	Sequence 32 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04907	RTCFYGLGKCRRICRANEKKKERCGERTFCCLR	33	Sequence 33 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04908	RICGYGTARCRKKCRSQEYRIGRCPNTYACCLR	33	Sequence 34 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04909	NPCELYQGMCRNACREYEIQYLTCPNDQKCCLK	33	Sequence 35 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04910	IACELYQGLCRNACQKYEIQYLSCPKTRKCCLK	33	Sequence 36 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04911	LRCMGNSGICRASCKKNEQPYLYCRNCQSCCLQ	33	Sequence 37 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04912	LQCMGNRGFCRSSCKKSEQAYFYCRTFQMCCLQ	33	Sequence 38 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04913	KKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCAN	34	Sequence 39 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04914	KRCFSNVEGYCRKKCRLVEISEMGCLHGKYCC	32	Sequence 40 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04915	KKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLN	35	Sequence 41 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04916	KSCWIIKGHCRKNCKPGEQVKKPCKNGDYCCIP	33	Sequence 42 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04917	KACWVLRGHCRKHCRSGERVRKPCSNGDYCC	31	Sequence 43 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04918	KKCWNRSGHCRKQCKDGEAVKDTCKNLRACCIP	33	Sequence 44 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04919	KRCLKILGHCRRHCKDGEMDHGSCKYYRVCCVP	33	Sequence 45 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04920	VECWMDGHCRLLCKDGEDSIIRCRNRKRCCVP	32	Sequence 46 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04921	QKCWKNNVGHCRRRCLDTERYILLCRNKLSCCIS	34	Sequence 47 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04922	KCWKNSLGYCRVRCQEEERYIYLCKNKVSCCIH	33	Sequence 48 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04923	KRCWKGQGACQTYCTRQETYMHLCPDASLCCLS	33	Sequence 49 from Patent US 20030176652	Homo sapiens	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04924	KRCWNGQGACRTFCTRQETFMHLCPDASLCCLS	33	Sequence 50 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04925	MKCWGKSGRCRTTCKESEVYYILCKTEAKCCVD	33	Sequence 55 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04926	DTCWKLKGICRNTCQKEEIYHIFCGIQSLCCLE	33	Sequence 56 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04927	RECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQ	34	Sequence 57 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04928	KECKMRRGHCKLQCSEKELRISFCIRPGTHCC	32	Sequence 58 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04929	KSCTAIGGRCKNQCDDSEFRISYCARPTTHCCVT	34	Sequence 59 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04930	DRCTKRYGRCKRDCLESEKQIDICSLPRKICCTE	34	Sequence 60 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04931	VDCRRSEGFCQEYCNYMETQVGYCSKKKDACCLH	34	Sequence 61 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04932	VNCKKSEGQCQEYCNFMETQVGYCSKKKEPCCLH	34	Sequence 62 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04933	ERCEKVRGICKTFCDDVEYDYGYCIKWRSQCCV	33	Sequence 63 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04934	ERCEKVRGMCKTVCDIDEYDYGYCIRWRNQCCI	33	Sequence 64 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04935	KRECQLVRGACKPECNSWEYVYYYCNVNPCCAV	33	Sequence 65 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04936	HKCSLVRGTCKSECNSWEYKYNYCHTEPCCVV	32	Sequence 66 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04937	ETCRLGRGKCRRTCIESEKIAGWCKLNFFCCRE	33	Sequence 67 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04938	ETCRLGRGKCRRACIESEKIVGWCKLNFFCCRE	33	Sequence 68 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04939	ESCKLGRGKCRKECLENEKPDGNCRLNFLCCRQ	33	Sequence 69 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04940	TNCFLYLARTAIHRALISKRMEGHCEAECLTFEVKIGGCRAELAPFCCKN	50	Sequence 70 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04941	FLCKKMNGQCEAECFTFEQKIGTCQANFLCCRK	33	Sequence 71 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04942	EKCSRVNGRCTASCLKNEELVALCQKNLKCCVT	33	Sequence 72 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04943	EKCSRINGRCTASCLKNEELVALCWKNLKCCVT	33	Sequence 73 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04944	EKCNKLKGTCKNNCGKNEELIALCQKSLKCCRT	33	Sequence 74 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04945	EICERPNGSCRDFCLETEIHVGRCLNSRPCCLP	33	Sequence 75 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04946	KLCLDQKDTCPDSRTCLEGTQPCHPHHPNCCES	33	Sequence 76 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04947	RPCEKMGGICKSQKTHGCSILPAECKSRYKHCCRL	35	Sequence 77 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04948	CRSWGTCSIAAICFDSLSRRGQCGPVKDPCCPL	33	Sequence 78 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04949	LTCIANRGFCWHSCIQGFQLAGHCGHPKVRLLH	33	Sequence 80 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04950	LVCRRKGGRCYIKCPDNTDZIGMCRLPFKCCKRQ	34	Sequence 81 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04951	LSCWMKZGICQYRCFGNTHKIGSCGAPFLKCCKR	34	Sequence 82 from Patent US 20030176652	Mus musculus	Antimicrobial	US 2003/0176652 A1	Patent Application	2003##9##18	"US20050277176, WO2003024992A2, WO2003024992A3"	"Human and mouse beta-defensins, antimicrobial peptides."	The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 beta-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the beta-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
DRAMP04952	XCRRLCYKQRCVTYCRGR	18	Sequence 1 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04953	XCRRLCYKQRCVTYCRGX	18	Sequence 2 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04954	XCKRLCYKQRCVTYCRGR	18	Sequence 3 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04955	XCHRLCYKQRCVTYCRGR	18	Sequence 4 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04956	XCRKLCYKQRCVTYCRGR	18	Sequence 5 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04957	XCRHLCYKQRCVTYCRGR	18	Sequence 6 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04958	XCRRYCYKQRCVTYCRGR	18	Sequence 7 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04959	XCRRVCYKQRCVTYCRGR	18	Sequence 8 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04960	XCRRICYKQRCVTYCRGR	18	Sequence 9 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04961	XCRRMCYKQRCVTYCRGR	18	Sequence 10 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04962	XCRRFCYKQRCVTYCRGR	18	Sequence 11 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04963	XCRRWCYKQRCVTYCRGR	18	Sequence 12 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04964	XCRRLCLKQRCVTYCRGR	18	Sequence 13 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04965	XCRRLCVKQRCVTYCRGR	18	Sequence 14 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04966	XCRRLCIKQRCVTYCRGR	18	Sequence 15 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04967	XCRRLCMKQRCVTYCRGR	18	Sequence 16 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04968	XCRRLCFKQRCVTYCRGR	18	Sequence 17 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04969	XCRRLCWKQRCVTYCRGR	18	Sequence 18 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04970	XCRRLCYRQRCVTYCRGR	18	Sequence 19 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04971	XCRRLCYHQRCVTYCRGR	18	Sequence 20 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04972	XCRRLCYKNRCVTYCRGR	18	Sequence 21 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04973	XCRRLCYKQKCVTYCRGR	18	Sequence 22 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04974	XCRRLCYKQHCVTYCRGR	18	Sequence 23 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04975	XCRRLCYKQRCLTYCRGR	18	Sequence 24 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04976	XCRRLCYKQRCYTYCRGR	18	Sequence 25 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04977	XCRRLCYKQRCITYCRGR	18	Sequence 26 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04978	XCRRLCYKQRCMTYCRGR	18	Sequence 27 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04979	XCRRLCYKQRCFTYCRGR	18	Sequence 28 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04980	XCRRLCYKQRCWTYCRGR	18	Sequence 29 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04981	XCRRLCYKQRCVGYCRGR	18	Sequence 30 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04982	XCRRLCYKQRCVSYCRGR	18	Sequence 31 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04983	XCRRLCYKQRCVAYCRGR	18	Sequence 32 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04984	XCRRLCYKQRCVTLCRGR	18	Sequence 33 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04985	XCRRLCYKQRCVTVCRGR	18	Sequence 34 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04986	XCRRLCYKQRCVTICRGR	18	Sequence 35 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04987	XCRRLCYKQRCVTMCRGR	18	Sequence 36 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04988	XCRRLCYKQRCVTFCRGR	18	Sequence 37 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04989	XCRRLCYKQRCVTWCRGR	18	Sequence 38 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04990	XCRRLCYKQRCVTYCKGR	18	Sequence 39 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04991	XCRRLCYKQRCVTYCHGR	18	Sequence 40 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04992	XCRRLCYKQRCVTYCRTR	18	Sequence 41 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04993	XCRRLCYKQRCVTYCRSR	18	Sequence 42 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04994	XCRRLCYKQRCVTYCRAR	18	Sequence 43 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04995	XCRRLCYKQRCVTYCRGK	18	Sequence 44 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04996	XCKHICFKNRCWSVCKGR	18	Sequence 45 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04997	XCRHLCYKNKCVTYCRGK	18	Sequence 46 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04998	XCRRVCYRQRCVGICHTR	18	Sequence 47 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP04999	XCHKMCLKQHCYAWCRGR	18	Sequence 48 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05000	XCHRLCIHQRCVTYCKAK	18	Sequence 49 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05001	XCRRYCMRQRCVTYCRGR	18	Sequence 50 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05002	XCHKFCLKNKCFSYCKTR	18	Sequence 51 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05003	XCKRLCYKQRCVTYCRGX	18	Sequence 52 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05004	XCHRLCYKQRCVTYCRGX	18	Sequence 53 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05005	XCRKLCYKQRCVTYCRGX	18	Sequence 54 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05006	XCRHLCYKQRCVTYCRGX	18	Sequence 55 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05007	XCRRYCYKQRCVTYCRGX	18	Sequence 56 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05008	XCRRVCYKQRCVTYCRGX	18	Sequence 57 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05009	XCRRICYKQRCVTYCRGX	18	Sequence 58 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05010	XCRRMCYKQRCVTYCRGX	18	Sequence 59 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05011	XCRRFCYKQRCVTYCRGX	18	Sequence 60 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05012	XCRRWCYKQRCVTYCRGX	18	Sequence 61 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05013	XCRRLCLKQRCVTYCRGX	18	Sequence 62 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05014	XCRRLCVKQRCVTYCRGX	18	Sequence 63 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05015	XCRRLCIKQRCVTYCRGX	18	Sequence 64 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05016	XCRRLCMKQRCVTYCRGX	18	Sequence 65 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05017	XCRRLCFKQRCVTYCRGX	18	Sequence 66 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05018	XCRRLCWKQRCVTYCRGX	18	Sequence 67 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05019	XCRRLCYRQRCVTYCRGX	18	Sequence 68 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05020	XCRRLCYHQRCVTYCRGX	18	Sequence 69 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05021	XCRRLCYKNRCVTYCRGX	18	Sequence 70 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05022	XCRRLCYKQKCVTYCRGX	18	Sequence 71 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05023	XCRRLCYKQHCVTYCRGX	18	Sequence 72 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05024	XCRRLCYKQRCLTYCRGX	18	Sequence 73 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05025	XCRRLCYKQRCYTYCRGX	18	Sequence 74 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05026	XCRRLCYKQRCITYCRGX	18	Sequence 75 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05027	XCRRLCYKQRCMTYCRGX	18	Sequence 76 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05028	XCRRLCYKQRCFTYCRGX	18	Sequence 77 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05029	XCRRLCYKQRCWTYCRGX	18	Sequence 78 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05030	XCRRLCYKQRCVGYCRGX	18	Sequence 79 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05031	XCRRLCYKQRCVSYCRGX	18	Sequence 80 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05032	XCRRLCYKQRCVAYCRGX	18	Sequence 81 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05033	XCRRLCYKQRCVTLCRGX	18	Sequence 82 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05034	XCRRLCYKQRCVTVCRGX	18	Sequence 83 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05035	XCRRLCYKQRCVTICRGX	18	Sequence 84 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05036	XCRRLCYKQRCVTMCRGX	18	Sequence 85 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05037	XCRRLCYKQRCVTFCRGX	18	Sequence 86 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05038	XCRRLCYKQRCVTWCRGX	18	Sequence 87 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05039	XCRRLCYKQRCVTYCKGX	18	Sequence 88 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05040	XCRRLCYKQRCVTYCHGX	18	Sequence 89 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05041	XCRRLCYKQRCVTYCRTX	18	Sequence 90 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05042	XCRRLCYKQRCVTYCRSX	18	Sequence 91 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05043	XCRRLCYKQRCVTYCRAX	18	Sequence 92 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05044	XCKHICFKNRCWSVCKGX	18	Sequence 94 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05045	XCRHLCYKNKCVTYCRGX	18	Sequence 95 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05046	XCRRVCYRQRCVGICHTX	18	Sequence 96 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05047	XCHKMCLKQHCYAWCRGX	18	Sequence 97 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05048	XCHRLCIHQRCVTYCKAX	18	Sequence 98 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05049	XCRRYCMRQRCVTYCRGX	18	Sequence 99 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05050	XCHKFCLKNKCFSYCKTX	18	Sequence 100 from Patent US 20030186854	Arachinid	"Antimicrobial, Antiparasitic, Antifungal"	US 2003/0186854 A1	Patent Application	2003##10##2	"US7723468, US20060276380, WO2001092290A2, WO2001092290A3"	"Antimicrobial peptide, process to obtain a peptide and uses therefor."	"The invention refers to small peptides with low hemolytic activity, presenting equal antiparasitic, antifungal and antibacterial activities. More specifically, it refers to a peptide called gomesin, with 18 amino acid residues, configured as a clamp-like structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cystein forming two disulphide bridges, optionally configurable as a cyclic chain with closed edges."
DRAMP05051	PGPIPN	6	Sequence 1 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05052	TTMPLW	6	Sequence 2 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05053	AVESTVATLEASPEVIESPPE	21	Sequence 3 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05054	AVESTVATLEDSPEVIESPPE	21	Sequence 4 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05055	DMPIQAFLLYQQPVLGPVR	19	Sequence 7 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05056	MAIPPKKNQDKTEIPTINTIASGEPTSTPTIEAVESTVATLEASPEVIESPPEINTVQVTSTAV	64	Sequence 8 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05057	MAIPPKKNQDKTEIPTINTIASGEPTSTPTTEAVESTVATLEDSPEVIESPPEINTVQVTSTAV	64	Sequence 10 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05058	TEIPTINTIASGEPTSTPTIEAVESTVATLEASPEVIESPPEINTVQVTSTAV	53	Sequence 12 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05059	TEIPTINTIASGEPTSTPTTEAVESTVATLEDSPEVIESPPEINTVQVTSTAV	53	Sequence 14 from Patent US 20030195150	Bovine	Antimicrobial	US 2003/0195150 A1	Patent Application	2003##10##16	"CA2311389A1, CA2311389C, DE69838143D1, DE69838143T2, EP1032592A1, EP1032592A4, EP1032592B1, US7588752, WO1999026971A1"	Antimicrobial peptides.	"The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEASigmaPEVIESPPE (SEQ ID NO:3), AVESTVATLEDSigmaPEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein."
DRAMP05060	DPAA	4	Sequence 3 from Patent US 20030228654	Hordeum vulgare	Antimicrobial	US 2003/0228654 A1	Patent Application	2003##12##11	"Masana Hirai, Takao Imaeda, Katsunori Kohda, Nobuhiko Muramoto, Takashi Shimamura, Yukio Yamada"	Method for producing antimicrobial protein and fusion protein.	"A basic antimicrobial protein is activated by a partner protein having an isoelectric point below pH 7 and a chaperon function, by expressing an antimicrobially inactive fusion protein between the basic antimicrobial protein and the partner protein, recovering the fusion protein and separating the two proteins from each other. In such manner, an advantageous mass expression system of the basic antimicrobial protein having an appropriate disulfide bond as an active type is realized at lost cost."
DRAMP05061	DKHMIEGRMKSCCRSTLGRNCYNLCRVRGAQKLCAGVCRCKLTSSGKCPTGFPK	54	Sequence 8 from Patent US 20030228654	Hordeum vulgare	Antimicrobial	US 2003/0228654 A1	Patent Application	2003##12##11	"Masana Hirai, Takao Imaeda, Katsunori Kohda, Nobuhiko Muramoto, Takashi Shimamura, Yukio Yamada"	Method for producing antimicrobial protein and fusion protein.	"A basic antimicrobial protein is activated by a partner protein having an isoelectric point below pH 7 and a chaperon function, by expressing an antimicrobially inactive fusion protein between the basic antimicrobial protein and the partner protein, recovering the fusion protein and separating the two proteins from each other. In such manner, an advantageous mass expression system of the basic antimicrobial protein having an appropriate disulfide bond as an active type is realized at lost cost."
DRAMP05062	DKHMIEGRKSCCRSTLGRNCYNLCRVRGAQKLCAGVCRCKLTSSGKCPTGFPKMIEGRETSSATETTTETATKSEEAAKETATEHDEL	88	Sequence 11 from Patent US 20030228654	Hordeum vulgare	Antimicrobial	US 2003/0228654 A1	Patent Application	2003##12##11	"Masana Hirai, Takao Imaeda, Katsunori Kohda, Nobuhiko Muramoto, Takashi Shimamura, Yukio Yamada"	Method for producing antimicrobial protein and fusion protein.	"A basic antimicrobial protein is activated by a partner protein having an isoelectric point below pH 7 and a chaperon function, by expressing an antimicrobially inactive fusion protein between the basic antimicrobial protein and the partner protein, recovering the fusion protein and separating the two proteins from each other. In such manner, an advantageous mass expression system of the basic antimicrobial protein having an appropriate disulfide bond as an active type is realized at lost cost."
DRAMP05063	ILKKWPWWPWRRK	13	Sequence 1 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05064	ILKPWKWPWWPWRRKK	16	Sequence 2 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05065	ILKPWKWPWWPWRR	14	Sequence 3 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05066	ILPWKKWPWWRWRR	14	Sequence 4 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05067	ILKKWPWWPWRR	12	Sequence 5 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05068	ILPWKWPWWPWRKWR	15	Sequence 6 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05069	ILPWKWPWWPWRRWR	15	Sequence 7 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05070	ILPWKWPWWPWKKWK	15	Sequence 8 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05071	PWKWPWWPWRR	11	Sequence 9 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05072	ILPWKWPWRR	10	Sequence 10 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05073	ILPWKWPWWPWWPWRR	16	Sequence 11 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05074	ILPWKWPWWPWWKKPWRR	18	Sequence 12 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05075	ILPWICPWRPSKAN	14	Sequence 13 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05076	IVPWKWTLWPWRR	13	Sequence 14 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05077	TLPCLWPWWPWSI	13	Sequence 15 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05078	ILPWKWPWWPWRR	13	Sequence 16 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05079	ILKKWPWWPWKRR	13	Sequence 17 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05080	ILKKWPWWPWKWKK	14	Sequence 18 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05081	ILPWKWPWYVRR	12	Sequence 19 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05082	IKWPWYVWL	9	Sequence 20 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05083	ILPWKWFFPPWPWRR	15	Sequence 21 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05084	ILPWKWPPWPPWPWRR	16	Sequence 22 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05085	ILKKWPWWRWRR	12	Sequence 27 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05086	ILKKFPFFPFRRK	13	Sequence 28 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05087	ILKKFPFFPFKKK	13	Sequence 29 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05088	ILKKWAWWPWRRK	13	Sequence 30 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05089	ILKKWPWWAWRRK	13	Sequence 31 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05090	ILKKWPWWPWKKK	13	Sequence 32 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05091	ILRRWPWWPWRRR	13	Sequence 33 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05092	WWKKWPWWPWRRK	13	Sequence 34 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05093	FFKKWPWWPWRRK	13	Sequence 35 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05094	FFKKFPFFPFRRK	13	Sequence 36 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05095	FFKKFPFFPFKKK	13	Sequence 37 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05096	ILKKWPWWPWWPWRRK	16	Sequence 38 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05097	ILKKWPWWPWRWWRR	15	Sequence 39 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05098	ILKKWPWWPWRRWWK	15	Sequence 40 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05099	ILKKWPWWPWPPRRK	15	Sequence 41 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05100	ILKKWPWWPWPPFFRRK	17	Sequence 42 from Patent US 20040019181	Synthetic construct	Antimicrobial	US 2004/0019181 A1	Patent Application	2004##1##29	"CA2230160A1, DE69637731D1, EP0846128A2, EP0846128B1, US6191254, US7390873, WO1997008199A2, WO1997008199A3"	Antimicrobial cationic peptides.	"A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."
DRAMP05101	MFLKAVVLTVALVAITGTQAEVTSDQVANV	30	Sequence 1 from Patent US 20040037781	Synthetic construct	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05102	AYLDEELQTELYEIKHQILQTMGVLSLQGSMLSVGDKVSTNGQSVNFDTIKEMCTFRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMIEDQ	93	Sequence 3 from Patent US 20040037781	Rat	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05103	AHLDEELQATLHDFRHQILQTRGALSLQGSIMTVGEKVFSSNGQSITFDAIQEACARAGGRIAVPRNPEENEAIASFVKKYNTYAYVGLTEGP	93	Sequence 6 from Patent US 20040037781	Homo sapiens	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05104	DVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDS	96	Sequence 11 from Patent US 20040037781	Homo sapiens	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05105	AYLDEELQTELYEIKHQILQTMGVLSLQGSMLSVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMIED	92	Sequence 15 from Patent US 20040037781	Synthetic construct	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05106	TPGDFHYLDGASVNYTNWYPG	21	Sequence 16 from Patent US 20040037781	Synthetic construct	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05107	SPGDFRYSDGTPVNYTNWYRG	21	Sequence 17 from Patent US 20040037781	Synthetic construct	Antimicrobial	US 2004/0037781 A1	Patent Application	2004##2##26	"US7273847, US20080020983, WO2002006301A2, WO2002006301A3"	Peptides with antioxidant and antimicrobial properties.	Methods of treating conditions associated with lipid oxidation or microbial proliferation include the step of administering a composition comprising a pharmacologically effective amount of an antioxidant or antimicrobial lung surfactant protein compound. Peptides derived from lung surfactant protein compounds possess lipid oxidation inhibiting and/or antimicrobial properties.
DRAMP05108	NQGRHFCGGALIHARFVMTAASCFQ	25	Sequence 1 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05109	RHFCGGALIHARFVMTAASC	20	Sequence 2 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05110	NQGRHFSGGALIHARFVMTAASCFQ	25	Sequence 3 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05111	RHFSGGALIHARFVMTAASC	20	Sequence 4 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05112	NQGRHFCGGALIHARFVMTAASSFQ	25	Sequence 5 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05113	RHFCGGALIHARFVMTAASS	20	Sequence 6 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05114	NQGRHFSGGALIHARFVMTAASSFQ	25	Sequence 7 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05115	RHFSGGALIHARFVMTAASS	20	Sequence 8 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05116	NQGRHFCGGALIHARFVMTAARCFQ	25	Sequence 10 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05117	NQGRHFCGGALIHARFVMTAAKCFQ	25	Sequence 11 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05118	RHFCGGALIHARFVMTAAHC	20	Sequence 12 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05119	RHFCGGALIHARFVMTAARC	20	Sequence 13 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05120	RHFCGGALIHARFVMTAAKC	20	Sequence 14 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05121	NQGRHFSGGALIHARFVMTAAHCFQ	25	Sequence 15 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05122	NQGRHFSGGALIHARFVMTAARCFQ	25	Sequence 16 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05123	NQGRHFSGGALIHARFVMTAAKCFQ	25	Sequence 17 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05124	NQGRHFCGGALIHARFVMTAAHSFQ	25	Sequence 18 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05125	NQGRHFCGGALIHARFVMTAARSFQ	25	Sequence 19 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05126	NQGRHFCGGALIHARFVMTAAKSFQ	25	Sequence 20 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05127	RHFSGGALIHARFVMTAAHC	20	Sequence 21 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05128	RHFSGGALIHARFVMTAARC	20	Sequence 22 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05129	RHFSGGALIHARFVMTAAKC	20	Sequence 23 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05130	RHFCGGALIHARFVMTAAHS	20	Sequence 24 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05131	RHFCGGALIHARFVMTAARS	20	Sequence 25 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05132	RHFCGGALIHARFVMTAAKS	20	Sequence 26 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05133	NQGRHFCAGALIHARFVMTAASCFQ	25	Sequence 27 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05134	NQGRHFCGAALIHARFVMTAASCFQ	25	Sequence 28 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05135	NQGRHFCAAALIHARFVMTAASCFQ	25	Sequence 29 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05136	NQGRHFSAGALIHARFVMTAASCFQ	25	Sequence 30 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05137	NQGRHFSGAALIHARFVMTAASCFQ	25	Sequence 31 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05138	NQGRHFSAAALIHARFVMTAASCFQ	25	Sequence 32 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05139	NQGRHFCAGALIHARFVMTAASSFQ	25	Sequence 33 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05140	NQGRHFCGAALIHARFVMTAASSFQ	25	Sequence 34 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05141	NQGRHFCAAALIHARFVMTAASSFQ	25	Sequence 35 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05142	NQGRHFCGGALIHARFVMTAATCFQ	25	Sequence 36 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05143	NQGRHFCGGALIHARFLMTAASCFQ	25	Sequence 37 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05144	NQGRHFCGGALIHARFIMTAASCFQ	25	Sequence 38 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05145	NQGRHFCGGALIHARFAMTAASCFQ	25	Sequence 39 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05146	NQGRHYCGGALIHARFVMTAASCFQ	25	Sequence 40 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05147	NQGRHFCGGALIHARYVMTAASCFQ	25	Sequence 41 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05148	NQGRHFCGGALIHARFVMTAASCYQ	25	Sequence 42 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05149	RHFSAGALIHARFVMTAASC	20	Sequence 43 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05150	RHFSGAALIHARFVMTAASC	20	Sequence 44 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05151	RHFSAAALIHARFVMTAASC	20	Sequence 45 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05152	RHFSGGALIHARFLMTAASC	20	Sequence 46 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05153	RHFSGGALIHARFIMTAASC	20	Sequence 47 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05154	RHFSGGALIHARFAMTAASC	20	Sequence 48 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05155	RHYSGGALIHARFVMTAASC	20	Sequence 49 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05156	RHFSGGALIHARYVMTAASC	20	Sequence 50 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05157	RHFCAGALIHARFVMTAASS	20	Sequence 51 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05158	RHFCGAALIHARFVMTAASS	20	Sequence 52 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05159	RHFCAAALIHARFVMTAASS	20	Sequence 53 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05160	RHFCGGALIHARFLMTAASS	20	Sequence 54 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05161	RHFCGGALIHARFIMTAASS	20	Sequence 55 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05162	RHFCGGALIHARFAMTAASS	20	Sequence 56 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05163	RHYCGGALIHARFVMTAASS	20	Sequence 57 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05164	RHFCGGALIHARYVMTAASS	20	Sequence 58 from Patent US 20040048792	Homo Sapiens	Antimicrobial	US 2004/0048792 A1	Patent Application	2004##3##11	"US6107460, US6514701, US6730659"	Antimicrobial peptides and methods of use thereof.	"Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated."
DRAMP05165	MKVFFLFAVLFCLVQTNSVHISHQEARGPSFRICVDFLGPRWARGCSTGN	50	Sequence 3 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05166	MKVFFLFAVLFCLVQTNSVHISHQEARGPSFKICVGFLGPRWARGCSTGN	50	Sequence 4 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05167	MKVFFLFAVLFCLVQTNSGDVPPGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	80	Sequence 9 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05168	MKVFFLFAVLFCLVQTNSGDVPLGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	80	Sequence 10 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05169	MRQRLLPSVTSLLLVALLFPEPASDLKVVDCRRSEGFCQEYCNYMETQVGYCSKKKDACCLH	62	Sequence 11 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05170	MRQRLLPSVTSLLLVALLFPEPASDLKVVDFRRSEGFCQEYCNYMETQVGYCPKKKDACCLH	62	Sequence 12 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05171	ARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQVHISHQEARGPSFRICVDFLGPRWARGCSTGN	79	Sequence 13 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05172	ARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQVHISHQEARGPSFKICVGFLGPRWARGCSTGN	79	Sequence 14 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05173	NSVHISHQEARGPSFRICVDFLGPRWARGCSTGN	34	Sequence 15 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05174	NSVHISHQEARGPSFKICVGFLGPRWARGCSTGN	34	Sequence 16 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05175	ARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQEPASDLKVVDCRRSEGFCQEYCNYMETQVGYCSKKKDACCLH	89	Sequence 17 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05176	ARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQEPASDLKVVDFRRSEGFCQEYCNYMETQVGYCPKKKDACCLH	89	Sequence 18 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05177	NSGDVPPGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	64	Sequence 21 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05178	NSGDVPLGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	64	Sequence 22 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05179	PASDLKVVDCRRSEGFCQEYCNYMETQVGYCSKKKDACCLH	41	Sequence 23 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05180	PASDLKVVDFRRSEGFCQEYCNYMETQVGYCPKKKDACCLH	41	Sequence 24 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05181	ARHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQ	47	Sequence 25 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05182	VHISHQEARGPSFRICVDFLGPRWARGCSTGN	32	Sequence 26 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05183	VHISHQEARGPSFKICVGFLGPRWARGCSTGN	32	Sequence 27 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05184	EPASDLKVVDCRRSEGFCQEYCNYMETQVGYCSKKKDACCLH	42	Sequence 28 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05185	EPASDLKVVDFRRSEGFCQEYCNYMETQVGYCPKKKDACCLH	42	Sequence 29 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05186	GDVPPGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	62	Sequence 30 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05187	GDVPLGIRNTICRMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI	62	Sequence 31 from Patent US 20040072777	Pan troglodytes	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05188	GNFLTGLGHRSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK	47	Sequence 63 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05189	GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	41	Sequence 64 from Patent US 20040072777	Homo sapiens	Antimicrobial	US 2004/0072777 A1	Patent Application	2004##4##15	"CA2396364A1, EP1246834A1, EP1246834A4, WO2001049702A1"	Epididymal antimicrobial peptides.	"The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, ""EP2 peptides"") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
DRAMP05190	KWRRWI	6	Sequence 1 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05191	KWRRWV	6	Sequence 3 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05192	KWIKWR	6	Sequence 5 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05193	KWVKWI	6	Sequence 7 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05194	KWIKWI	6	Sequence 9 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05195	KWIKWIKWI	9	Sequence 11 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05196	KFIKFIKFI	9	Sequence 13 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05197	KWRRWVRWI	9	Sequence 15 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05198	IWRVWRRWK	9	Sequence 17 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05199	KFRRFVRFI	9	Sequence 19 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05200	KPRRPVRPI	9	Sequence 21 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05201	KWIRWVRWI	9	Sequence 23 from Patent US 20040072990	Synthetic construct	Antimicrobial	US 2004/0072990 A1	Patent Application	2004##4##15	"CA2450540A1, DE10360435A1"	Antimicrobial peptides with reduced hemolysis and methods of their use.	The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
DRAMP05202	ACNFQSCWATCQAQHSIYFRRAFCDRSQCKCVFVRG	36	Sequence 2 from Patent US 20040087771	Pseudacanthotermes spinig	Antimicrobial	US 2004/0087771 A1	Patent Application	2004##5##6	"CA2410575A1, EP1294880A2, WO2002000706A2, WO2002000706A3"	"Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them."	"The invention concerns novel antimicrobial peptides of the family of defensins, in particular antifungal, called termicines, polynucleotides encoding said peptides, vectors containing them for transforming a host organism and the method for transforming said organism. The invention also concerns transformed organisms, in particular yeast producing termicine, or plant cells and plants, the termicines produced by the transformed plats providing them with resistence to fungus-mediated diseases. The invention further concerns the use of termicines as medicine and pharmaceutical compositions containing them."
DRAMP05203	SLDKRACNFQSCWATCQAQHSIYFRRAFCDRSQCKCVFVRG	41	Sequence 4 from Patent US 20040087771	Synthetic construct	Antimicrobial	US 2004/0087771 A1	Patent Application	2004##5##6	"CA2410575A1, EP1294880A2, WO2002000706A2, WO2002000706A3"	"Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them."	"The invention concerns novel antimicrobial peptides of the family of defensins, in particular antifungal, called termicines, polynucleotides encoding said peptides, vectors containing them for transforming a host organism and the method for transforming said organism. The invention also concerns transformed organisms, in particular yeast producing termicine, or plant cells and plants, the termicines produced by the transformed plats providing them with resistence to fungus-mediated diseases. The invention further concerns the use of termicines as medicine and pharmaceutical compositions containing them."
DRAMP05204	SRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKL	32	Sequence 1 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05205	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	Sequence 2 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05206	RLCRIVVIRVCR	12	Sequence 4 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05207	QLRYREAVLRAVDRLNEQSSEANLYRLLELDQPPKADEDPGTPKPVSFTVKETVCPRPTRQPPELCDFKEKQCVGTVTLNPSIHSLDISCNEIQSV	96	Sequence 6 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05208	GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS	37	Sequence 12 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05209	GRFKRFRKKFKKLFKKLSPVIPLLHLG	27	Sequence 14 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05210	GLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLAPRTDY	37	Sequence 15 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05211	RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPIRPPFRPPLGPFPGRR	46	Sequence 16 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05212	RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL	60	Sequence 17 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05213	RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFPGKR	42	Sequence 18 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05214	RGGRLCYCRRRFCICVG	17	Sequence 19 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05215	LFEAIEGFIFL	11	Sequence 20 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05216	GILGFVFTLT	10	Sequence 21 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05217	QYIKANSKFIGITE	14	Sequence 22 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05218	VYDFFVWL	8	Sequence 23 from Patent US 20040170642	Synthetic construct	Antimicrobial	US 2004/0170642 A1	Patent Application	2004##9##2	"CA2418854A1, EP1309345A2, US7658928, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05219	ILPWKWPWWPWRRG	14	Sequence 19 from Patent US 7658928	Synthetic construct	Antimicrobial	US 7658928 B2	Granted Patent	2010##2##9	"CA2418854A1, EP1309345A2, US20040170642, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05220	LFEAIEGFI	9	Sequence 22 from Patent US 7658928	Synthetic construct	Antimicrobial	US 7658928 B2	Granted Patent	2010##2##9	"CA2418854A1, EP1309345A2, US20040170642, US20080166368, WO2002013857A2, WO2002013857A3, WO2002013857A8"	Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide.	Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.
DRAMP05221	SLRCGSCRRIIQHLMDKLGDQPDENTVIEEASKVCSKMRLLKGLCKSIMKKFLRTIAEDIVAGKTSRVICVDIKMCKSKPVGFI	84	Sequence 23 from Patent US 20040204575	Bos taurus	Antimicrobial	US 2004/0204575 A1	Patent Application	2004##10##14	US7160696	Bovine lymphocyte-derived antibacterial protein.	"A nucleic acid sequence encoding a polypeptide having antibacterial activity, which nucleic acid sequence has the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13 or is a nucleic acid that hybridizes under highly stringent conditions to a complement of a nucleic acid having the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13, and the polypeptide encoded thereby."
DRAMP05222	GLICESCRKIIQKLEDMVGPQPNEDTVTQAASRVCDKMKILRGVCKKIMRTFLRRISKDILTGKKPQAICVDIKICKEKTGLI	83	Sequence 24 from Patent US 20040204575	Sus scrofa	Antimicrobial	US 2004/0204575 A1	Patent Application	2004##10##14	US7160696	Bovine lymphocyte-derived antibacterial protein.	"A nucleic acid sequence encoding a polypeptide having antibacterial activity, which nucleic acid sequence has the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13 or is a nucleic acid that hybridizes under highly stringent conditions to a complement of a nucleic acid having the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13, and the polypeptide encoded thereby."
DRAMP05223	GRDYRTCLTIVQKLKKMVDKPTQRSVSNAATRVCRTGRSRWRDVCRNFMRRYQSRVTQGLVAGETAQQICEDLRLCIPSTGPL	83	Sequence 25 from Patent US 20040204575	Homo sapiens	Antimicrobial	US 2004/0204575 A1	Patent Application	2004##10##14	US7160696	Bovine lymphocyte-derived antibacterial protein.	"A nucleic acid sequence encoding a polypeptide having antibacterial activity, which nucleic acid sequence has the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13 or is a nucleic acid that hybridizes under highly stringent conditions to a complement of a nucleic acid having the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13, and the polypeptide encoded thereby."
DRAMP05224	MTSWAVLLITSVLL	14	Sequence 28 from Patent US 20040204575	Bos taurus	Antimicrobial	US 2004/0204575 A1	Patent Application	2004##10##14	US7160696	Bovine lymphocyte-derived antibacterial protein.	"A nucleic acid sequence encoding a polypeptide having antibacterial activity, which nucleic acid sequence has the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13 or is a nucleic acid that hybridizes under highly stringent conditions to a complement of a nucleic acid having the nucleotide sequence of Bases 198 to 452 of Seq. ID No. 13, and the polypeptide encoded thereby."
DRAMP05225	MRLVVCLVFLASFALVCQAQGYQGGYTRPFPRPPYGGGYHPVPVCTSCHRLSPLQARACCRQLGRCCDAKQTYG	74	Sequence 1 from Patent US 20040235738	Penaeus monodon	Antimicrobial	US 2004/0235738 A1	Patent Application	2004##11##25	"US7670836, US20080032385"	Novel antimicrobial peptide isolated from penaeus monodon.	"The present invention provides an antimicrobial peptide, monodoncin, which is isolated and purified from Penaeus monodon and is capable of being mass produced by molecular cloning techniques in a heterologous expression system, such as yeast. Monodoncin demonstrates a wide-range of bacteriostatic and bactericidal effects on G(-) and G(+) bacteria as well as fungicidal activities, and can be used in combination with conventional antibiotics as ""cocktail therapy"" to improve the therapeutic effects of the conventional antibiotics."
DRAMP05226	KKAAAXAAAAAXAAXAAXAAAKKKK	25	Sequence 1 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05227	KKAAAXAAAAAXAAWAAXAAAKKKK	25	Sequence 2 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05228	KKAAAFAAAAAFAAWAAFAAAKKKK	25	Sequence 3 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05229	KKAAAWAAAAAWAAWAAWAAAKKKK	25	Sequence 4 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05230	KKAAALAAAAALAAWAALAAAKKKK	25	Sequence 5 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05231	KKAAAIAAAAAIAAWAAIAAAKKKK	25	Sequence 6 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05232	KKAAAYAAAAAYAAWAAYAAAKKKK	25	Sequence 7 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05233	KKAAASAAAAASAAWAASAAAKKKK	25	Sequence 8 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05234	KKAFAAAAAFAAWAAFAKKKK	21	Sequence 9 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05235	KKKKKKAAFAAWAAFAA	17	Sequence 10 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05236	RRRAAFAAWAAFAARRR	17	Sequence 11 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05237	KKAAAAFAAFAAWFAAFAAAAKKKK	25	Sequence 12 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05238	KKAAAMAAAAAMAAWAAMAAAKKKK	25	Sequence 13 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05239	KKAAALAAAAACAAWAALAAAKKKK	25	Sequence 14 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05240	KKATALVGAASLTAWVGLASAKKKK	25	Sequence 15 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05241	KKAAAFAAAAAFAAXAAFAAAKKKK	25	Sequence 16 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05242	KKAAAWAAAAAWAAXAAWAAAKKKK	25	Sequence 17 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05243	KKAAALAAAAALAAXAALAAAKKKK	25	Sequence 18 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05244	KKAAAIAAAAAIAAXAAIAAAKKKK	25	Sequence 19 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05245	KKAAAYAAAAAYAAXAAYAAAKKKK	25	Sequence 20 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05246	KKAFAAAAAFAAXAAFAKKKK	21	Sequence 21 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05247	KKKKKAAAFAAXAAFA	16	Sequence 22 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05248	RRRAAAFAAXAAFARRR	17	Sequence 23 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05249	KKAAAAFAAFAAXFAAFAAAAKKKK	25	Sequence 24 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05250	KKAAAMAAAAAMAAXAAMAAAKKKK	25	Sequence 25 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05251	KKAAALAAAAACAAXAALAAAKKKK	25	Sequence 26 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05252	KKATALVGAASLTAXVGLASAKKKK	25	Sequence 27 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05253	KKAAAVAAAAAVAAWAAVAAAKKKK	25	Sequence 28 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05254	KKAAAAAAAAAAAAWAAAAAAKKKK	25	Sequence 29 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05255	KKAAATAAAAATAAWAATAAAKKKK	25	Sequence 30 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05256	KKAAAGAAAAAGAAWAAGAAAKKKK	25	Sequence 31 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05257	KKAAANAAAAANAAWAANAAAKKKK	25	Sequence 32 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05258	KKKKKKAAAFAAAAAFAAWAAFAAA	25	Sequence 33 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05259	KKKAAAFAAWAAFAKKK	17	Sequence 34 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05260	RRRRRRAAFAAWAAFAA	17	Sequence 36 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05261	KKKKKKAAAAFWAAAAF	17	Sequence 37 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05262	KKKKKKAAFAAFAAFAA	17	Sequence 38 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05263	KKKKKKAAWAAWAAWAA	17	Sequence 39 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05264	KKAAAVAAAAAVAAXAAVAAAKKKK	25	Sequence 40 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05265	KKAAAAAAAAAAAAXAAAAAAKKKK	25	Sequence 41 from Patent US 20040235745	Synthetic construct	Antimicrobial	US 2004/0235745 A1	Patent Application	2004##11##25	"CA2451310A1, CN1516598A, EP1401478A2, WO2003000277A2, WO2003000277A3"	Antimicrobial Peptides.	"A method is described for treating a microbial infection with a peptide whose amino acid sequence has a formula selected from the group consisting of: (a) B n1 -Z; (b) B n1 -Z-B n2; and (c) Z-B n1 wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of about 11 to about 24 amino acid residues, the sequence having an average hydrophobicity value of at least 0.3, and preferably at least 0.4. These peptides show antimicrobial activity against microorganisms including both Gram-positive and Gram-negative bacteria."
DRAMP05266	GWFKKAWRKVKHAGRRVLDTAKGVGRHYLNNWLNRYRG	38	Sequence 5 from Patent US 20040249143	Myxine glutinosa	Antimicrobial	US 2004/0249143 A1	Patent Application	2004##12##9	"CA2455918A1, EP1499633A2, EP1499633A4, WO2003012044A2, WO2003012044A3, WO2003012044A9"	Hagfish cathelin-associated antimicrobial peptides and genes.	The present invention includes Myxine glutinosa cathelin-associated antimicrobial peptides and genes encoding these peptides. The invention also includes compositions an methods for producing these peptides as well as method of preventing and treating microbial infections using these peptides.
DRAMP05267	GWFKKAWRKVKNAGRVLKGVGIHYGVGLIG	30	Sequence 6 from Patent US 20040249143	Myxine glutinosa	Antimicrobial	US 2004/0249143 A1	Patent Application	2004##12##9	"CA2455918A1, EP1499633A2, EP1499633A4, WO2003012044A2, WO2003012044A3, WO2003012044A9"	Hagfish cathelin-associated antimicrobial peptides and genes.	The present invention includes Myxine glutinosa cathelin-associated antimicrobial peptides and genes encoding these peptides. The invention also includes compositions an methods for producing these peptides as well as method of preventing and treating microbial infections using these peptides.
DRAMP05268	GFFKKAXRKVKHAGRRVLDTAKGVGRHYVNNXLNRYRZ	38	Sequence 9 from Patent US 20040249143	Myxine glutinosa	Antimicrobial	US 2004/0249143 A1	Patent Application	2004##12##9	"CA2455918A1, EP1499633A2, EP1499633A4, WO2003012044A2, WO2003012044A3, WO2003012044A9"	Hagfish cathelin-associated antimicrobial peptides and genes.	The present invention includes Myxine glutinosa cathelin-associated antimicrobial peptides and genes encoding these peptides. The invention also includes compositions an methods for producing these peptides as well as method of preventing and treating microbial infections using these peptides.
DRAMP05269	GXFKKAXRKVKNAGRRVLKGVGIHYGVGLIZ	31	Sequence 10 from Patent US 20040249143	Myxine glutinosa	Antimicrobial	US 2004/0249143 A1	Patent Application	2004##12##9	"CA2455918A1, EP1499633A2, EP1499633A4, WO2003012044A2, WO2003012044A3, WO2003012044A9"	Hagfish cathelin-associated antimicrobial peptides and genes.	The present invention includes Myxine glutinosa cathelin-associated antimicrobial peptides and genes encoding these peptides. The invention also includes compositions an methods for producing these peptides as well as method of preventing and treating microbial infections using these peptides.
DRAMP05270	MRVLYLLFSFLFIFLMPLPGVFGGIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	64	Sequence 2 from Patent US 20050004355	Synthetic construct	Antimicrobial	US 2005/0004355 A1	Patent Application	2005##1##6	"CA2290781A1, CN1260834A, EP0980431A1, US6143498, US6420116, US7223840, WO1998051794A1"	Antimicrobial peptide.	"The present invention relates to a novel human antimicrobial peptide which is a member of the defensin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human antimicrobial peptide. Antimicrobial peptide are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for detecting disorders related to the immune system and therapeutic methods for such disorders."
DRAMP05271	MRLHHLLLALLFLVLSAWSGFTQGVGNPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRK	63	Sequence 3 from Patent US 20050004355	Synthetic construct	Antimicrobial	US 2005/0004355 A1	Patent Application	2005##1##6	"CA2290781A1, CN1260834A, EP0980431A1, US6143498, US6420116, US7223840, WO1998051794A1"	Antimicrobial peptide.	"The present invention relates to a novel human antimicrobial peptide which is a member of the defensin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human antimicrobial peptide. Antimicrobial peptide are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for detecting disorders related to the immune system and therapeutic methods for such disorders."
DRAMP05272	ITFTG	5	Sequence 1 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05273	ACGGACAGATGCAGATTGG	19	Sequence 2 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05274	CCGAGGCCAGTTGAGATCAGTC	22	Sequence 3 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05275	ASPTYRLYSASPASPASPASPLYS	24	Sequence 5 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05276	GSRGKHTFVRPTLVF	15	Sequence 6 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05277	FISYSSPSHMGARMR	15	Sequence 7 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05278	AATTTAATACGACTCACTATAGGCAAACGACTGTCCTGGCCGT	43	Sequence 8 from Patent US 20050037972	Synthetic construct	Antimicrobial	US 2005/0037972 A1	Patent Application	2005##2##17	US7238669	Phage-display peptides as novel antimicrobial agents against haemophilus influenzae.	"Whole cell phage-display techniques were used to identify several peptides that bound preferentially to a non-typeable strain of Haemophilus influenzae. These peptides were able to inhibit growth of both H. influenzae and Staphylococcal aureus. Thus, methods for treating bacterial infections, alone or in combination with traditional antibiotics, are envisioned."
DRAMP05279	VAPIAKYLATALAKWALKQGFAKLKS	26	Sequence 1 from Patent US 20050043508	Synthetic construct	Antimicrobial	US 2005/0043508 A1	Patent Application	2005##2##24	US7041647	Synthetic peptide having an ionophoric and antimicrobial activity.	"This invention provides a novel synthetic peptide (P1) of 26 amino acids, which inhibits the microbial growing. Peptide P1 also shows ionophoric activity in rat liver mitochondria. Furthermore, this invention provides pharmaceutical compositions and compositions for agricultural use, which contain the peptide of the invention."
DRAMP05280	GNNRPVYIPQPRPPHPRI	18	Sequence 1 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05281	KKAAAKAAAAAKAAWAAKAAAKKKK	25	Sequence 2 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05282	KRRWPWWPWKKLI	13	Sequence 7 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05283	ILKKIPIIPIRRK	13	Sequence 9 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05284	ILKKYPYYPYRRK	13	Sequence 10 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05285	ILKKWPWPWRRK	12	Sequence 11 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05286	ILKKYPWYPWRRK	13	Sequence 12 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05287	ILKKFPWFPWRRK	13	Sequence 13 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05288	ILKKFPFWPWRRK	13	Sequence 14 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05289	ILRYVYYVYRRK	12	Sequence 15 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05290	ILRWPWWPWWPWRRK	15	Sequence 16 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05291	WWRWPWWPWRRK	12	Sequence 17 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05292	ILRRWPWWPWRRK	13	Sequence 18 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05293	ILRRWPWWPWRK	12	Sequence 19 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05294	ILKWPWWPWRRK	12	Sequence 20 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05295	ILKKWPWWPWRK	12	Sequence 21 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05296	ILKWPWWPWRK	11	Sequence 22 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05297	ILRWPWWPWRRK	12	Sequence 23 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05298	KRRWPWWPWRLI	12	Sequence 24 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05299	ILWPWWPWRRK	11	Sequence 25 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05300	ILRWPWWPWRRKIMILKKAGS	21	Sequence 28 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05301	ILRWPWWPWRRKMILKKAGS	20	Sequence 29 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05302	ILRWPWWPWRRKDMILKKAGS	21	Sequence 30 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05303	ILRWPWRRWPWRRK	14	Sequence 31 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05304	ILRWPWWPWRRKILMRWPWWPWRRKMAA	28	Sequence 32 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05305	KRKWPWWPWRLI	12	Sequence 33 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05306	ILKWVWWVWRRK	12	Sequence 34 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05307	LKKWPWWPWRRK	12	Sequence 38 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05308	PWWPWRRK	8	Sequence 39 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05309	ILKKWPWWPWRRKMILKKAGS	21	Sequence 40 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05310	ILKKWPWWPWRRMILKKAGS	20	Sequence 41 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05311	ILKKWPWWPWRRIMILKKAGS	21	Sequence 42 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05312	WWPWRRK	7	Sequence 43 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05313	ILKKWPW	7	Sequence 44 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05314	ILKKWPWWPWRRKM	14	Sequence 45 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05315	ILKKWPWWPWRRM	13	Sequence 46 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05316	ILKKWPWWPWRRIM	14	Sequence 47 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05317	ILKKWWWPWRK	11	Sequence 48 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05318	ILKKWPWWWRK	11	Sequence 49 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05319	WRIWKPKWRLPKW	13	Sequence 50 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05320	CLRWPWWPWRRK	12	Sequence 51 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05321	ILKKWVWWVWRRK	13	Sequence 55 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05322	ILKKWPWWVWRRK	13	Sequence 56 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05323	ILKKWVWWPWRRK	13	Sequence 57 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05324	ILRWVWWVWRRK	12	Sequence 58 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05325	KRRWVWWVWRLI	12	Sequence 59 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05326	ILRRWVWWVWRRK	13	Sequence 60 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05327	ILRWWVWWVWWRRK	14	Sequence 61 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05328	RLWVWWVWRRK	11	Sequence 62 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05329	RLWVWWVWRR	10	Sequence 63 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05330	RLGGGWVWWVWRR	13	Sequence 64 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05331	RLWWVVWWRR	10	Sequence 65 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05332	RLVVWWVVRR	10	Sequence 66 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05333	RLFVWWVFRR	10	Sequence 67 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05334	RLVVWVVWRR	10	Sequence 68 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05335	WVRLWWRRVW	10	Sequence 71 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05336	IKKWPWWPWRRK	12	Sequence 72 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05337	ILKKPWWPWRRK	12	Sequence 73 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05338	ILKKWWWPWRRK	12	Sequence 74 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05339	ILKKWPWWWRRK	12	Sequence 75 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05340	ILKKWPWWPRRK	12	Sequence 76 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05341	ILKKWPWWPWK	11	Sequence 78 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05342	ILKKWPWWPWR	11	Sequence 79 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05343	LWPWWPWRRK	10	Sequence 80 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05344	LRWWWPWRRK	10	Sequence 81 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05345	LRWPWWPW	8	Sequence 82 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05346	WPWWPWRRK	9	Sequence 83 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05347	RWWWPWRRK	9	Sequence 84 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05348	ALRWPWWPWRRK	12	Sequence 85 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05349	IARWPWWPWRRK	12	Sequence 86 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05350	ILAWPWWPWRRK	12	Sequence 87 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05351	ILRAPWWPWRRK	12	Sequence 88 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05352	ILRWAWWPWRRK	12	Sequence 89 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05353	ILRWPAWPWRRK	12	Sequence 90 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05354	ILRWPWAPWRRK	12	Sequence 91 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05355	ILRWPWWAWRRK	12	Sequence 92 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05356	ILRWPWWPARRK	12	Sequence 93 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05357	ILRWPWWPWARK	12	Sequence 94 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05358	ILRWPWWPWRAK	12	Sequence 95 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05359	ILRWPWWPWRRA	12	Sequence 96 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05360	RRIWKPKWRLPKR	13	Sequence 97 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05361	WRWWKPKWRWPKW	13	Sequence 98 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05362	WRWWKVAWRWVKW	13	Sequence 100 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05363	WRWWKVWRWVKW	12	Sequence 101 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05364	WRWWKVVWRWVKW	13	Sequence 102 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05365	WXWWXVAWXWVXW	13	Sequence 103 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05366	WXWWXPXWXWPXW	13	Sequence 104 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05367	KKWWRRALQALKNGLPALIS	20	Sequence 109 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05368	KWKSFIKKLTSAAKKVLTTGLPALIS	26	Sequence 115 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05369	KWKLFIKKLTPAVKKVLLTGLPALIS	26	Sequence 116 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05370	GKPRPYSPIPTSPRPIRY	18	Sequence 117 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05371	RLARIVVIRVAR	12	Sequence 118 from Patent US 20050049182	Synthetic construct	Antimicrobial	US 2005/0049182 A1	Patent Application	2005##3##3	"CA2456477A1, DE60239707D1, EP1469876A2, EP1469876B1, US6835536, US8138144, US20030171281, US20120202735, WO2003015809A2, WO2003015809A3, WO2003015809A"	Antimicrobial cationic peptides and formulations thereof.	"Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."
DRAMP05372	MSDVIIPFLTSAVTAFIVAYLLDRWYIKRRR	31	Sequence 1 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05373	MRKFVTTLTASPRNKKVGNHRLEISPFVSLRRYYYFNTAICIENPVTREFAIDDSYGSLSTNQNCAQYRQYFSLGGYKEVSLEEIHAV	88	Sequence 6 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05374	MIQLSERQQDLLQVAEKYEQCHIEFYTAQSRLFGTEIMGEVVKTSLGTLKIAHPEEDLFEVALAYLASKKDILTAQERKDVLFYIQNNLC	90	Sequence 7 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05375	MMMDKQVEEVKKHYPIVEDWSVIVARKEDDCMTVTDAVPFILAGYKNVSYEMDDIVVLCSEPIGLTWEDVRFLKNHEGSVSFEEIGYEDKAMVYHVDLG	99	Sequence 9 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05376	MMTEDQKFKYLTKIEELEAGCFSDWTKEDITGDLKYLKKGIIEESIELIRAVNGLTYSEELHDFTQEIIEELDISPL	77	Sequence 10 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05377	MDWTKMTFMGTVDEVKEIWNGLEEAGRLYAVWLSDDHVYGIVDVNEEGLFCLGWVSDISPESLQNMLGGGAELFESYEDVLSEHGGSIAIRVEV	94	Sequence 11 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05378	MDKLAAGGLYLLFLLLAGIIVTH	23	Sequence 14 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05379	MVIIKYTTKTQPTPVKEMFISPQHYAKWRSHMGSKLTSVKPIKGGR	46	Sequence 18 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05380	MFKLLTLFKRNKITSAEEYYTQAIHICEQFDRSTQKYTSM	40	Sequence 19 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05381	MFKYTDRSVRQYIERQQRSAMLEQEQAEKDKKERRKAGLLFFGTIVVLVAVVAVYIVPQSLDAMWHENYEKPAQEAARN	79	Sequence 20 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05382	MTLAGYRVDSCNGCGKAYLVGESHDRKKCAECASK	35	Sequence 22 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05383	MKKRYKVTALFEDGTSQCLVVGNFSSPTNAWCAAMRNLTPEGIARVQHYNVEEISK	56	Sequence 23 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05384	LNQVEVLREEYVEGYVVQMWRRNPSNAPVIEVFTEDNLEEGIIPEYVTANDDTFDRIVDAVEFGYLEELELV	72	Sequence 24 from Patent US 20050054571	SPO1 Bacteriophage	Antimicrobial	US 2005/0054571 A1	Patent Application	2005##3##10	US7157427	Antimicrobial proteins from the SPO1 bacteriophage.	Anti-bacterial peptides are provided which are derived from the bacteriophage SPO1.
DRAMP05385	KGLKKLLKGLKKLLKL	16	Sequence 1 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05386	KGLKKGLKLLKKLLKL	16	Sequence 2 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05387	KGLKKLLKLGKKLLKL	16	Sequence 3 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05388	KGLKKLGKLLKKLLKL	16	Sequence 4 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05389	KGLKKLLKLLKKGLKL	16	Sequence 5 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05390	KGLKKLLKLLKKLGKL	16	Sequence 6 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05391	KCLKKLLKLGKKLLKL	16	Sequence 7 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05392	KCLKKGLKLLKKLLKL	16	Sequence 8 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05393	KCLKKLLKGLKKLLKL	16	Sequence 9 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05394	KCLKKLGKLLKKLLKL	16	Sequence 10 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05395	KCLKKLGKLLKKLGKL	16	Sequence 11 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05396	KCLKKGLKLLKKLLKG	16	Sequence 12 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05397	KGLKKLLKLLKKLLKL	16	Sequence 13 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05398	KCLKKLLKLGKKLLKLC	17	Sequence 14 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05399	KCLKKGLKLLKKLLKLC	17	Sequence 15 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05400	KCLKKLLKLLKKLGKLC	17	Sequence 16 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05401	KCLKKLLKLLKKGLKLC	17	Sequence 17 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05402	KCLKKLLKGLKKLLKLC	17	Sequence 18 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05403	KCLKKLGKLLKKLLKLC	17	Sequence 19 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05404	KCLKKLGKLLKKLLKGC	17	Sequence 20 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05405	CLKKLLKLGKKLLKLC	16	Sequence 21 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05406	CLKKGLKLLKKLLKLC	16	Sequence 22 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05407	CLKKLLKLLKKLGKLC	16	Sequence 23 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05408	CLKKLLKLLKKGLKLC	16	Sequence 24 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05409	CLKKLLKGLKKLLKLC	16	Sequence 25 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05410	CLKKLGKLLKKLLKLC	16	Sequence 26 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05411	KGLKKGLKGLKKLLKL	16	Sequence 40 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05412	KGLKKLLKALKKLLKL	16	Sequence 41 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05413	KGGKKLLKGLKKLLKL	16	Sequence 43 from Patent US 20050065072	Synthetic construct	Antimicrobial	US 2005/0065072 A1	Patent Application	2005##3##24	"US7550430, WO2005019241A2, WO2005019241A3"	Cationic antimicrobial peptides and compositions.	"The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention."
DRAMP05414	MKTLTFYTLLLCAALYSNFFDCKAVADAELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFSKK	66	Sequence 6 from Patent US 20050069977	Oryctes rhinoceros	Antimicrobial	US 2005/0069977 A1	Patent Application	2005##3##31	"DE60219340D1, DE60219340T2, EP1443054A1, EP1443054A4, EP1443054B1, US7041808, WO2003033532A1"	"Antimicrobial proteins, genes encoding the proteins and method of using the same."	"It is intended to provide thermotolerant and antimicrobial proteins having a broad antibacterial spectrum and being useful in the agricultural, medical and industrial field; and plants resistant to pathogenic microorganisms. Namely, DNAs comprising the base sequences represented by SEQ ID NOS: 1 to 5 respectively; antimicrobial proteins encoded by these DNAs; and fungicides, antibacterial agents and antibacterial/antifungal agents for industrial use comprising the antimicrobial proteins as the active ingredient."
DRAMP05415	ELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFS	36	Sequence 7 from Patent US 20050069977	Oryctes rhinoceros	Antimicrobial	US 2005/0069977 A1	Patent Application	2005##3##31	"DE60219340D1, DE60219340T2, EP1443054A1, EP1443054A4, EP1443054B1, US7041808, WO2003033532A1"	"Antimicrobial proteins, genes encoding the proteins and method of using the same."	"It is intended to provide thermotolerant and antimicrobial proteins having a broad antibacterial spectrum and being useful in the agricultural, medical and industrial field; and plants resistant to pathogenic microorganisms. Namely, DNAs comprising the base sequences represented by SEQ ID NOS: 1 to 5 respectively; antimicrobial proteins encoded by these DNAs; and fungicides, antibacterial agents and antibacterial/antifungal agents for industrial use comprising the antimicrobial proteins as the active ingredient."
DRAMP05416	DAELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFS	38	Sequence 8 from Patent US 20050069977	Oryctes rhinoceros	Antimicrobial	US 2005/0069977 A1	Patent Application	2005##3##31	"DE60219340D1, DE60219340T2, EP1443054A1, EP1443054A4, EP1443054B1, US7041808, WO2003033532A1"	"Antimicrobial proteins, genes encoding the proteins and method of using the same."	"It is intended to provide thermotolerant and antimicrobial proteins having a broad antibacterial spectrum and being useful in the agricultural, medical and industrial field; and plants resistant to pathogenic microorganisms. Namely, DNAs comprising the base sequences represented by SEQ ID NOS: 1 to 5 respectively; antimicrobial proteins encoded by these DNAs; and fungicides, antibacterial agents and antibacterial/antifungal agents for industrial use comprising the antimicrobial proteins as the active ingredient."
DRAMP05417	ELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFSKK	38	Sequence 9 from Patent US 20050069977	Oryctes rhinoceros	Antimicrobial	US 2005/0069977 A1	Patent Application	2005##3##31	"DE60219340D1, DE60219340T2, EP1443054A1, EP1443054A4, EP1443054B1, US7041808, WO2003033532A1"	"Antimicrobial proteins, genes encoding the proteins and method of using the same."	"It is intended to provide thermotolerant and antimicrobial proteins having a broad antibacterial spectrum and being useful in the agricultural, medical and industrial field; and plants resistant to pathogenic microorganisms. Namely, DNAs comprising the base sequences represented by SEQ ID NOS: 1 to 5 respectively; antimicrobial proteins encoded by these DNAs; and fungicides, antibacterial agents and antibacterial/antifungal agents for industrial use comprising the antimicrobial proteins as the active ingredient."
DRAMP05418	DAELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFSKK	40	Sequence 10 from Patent US 20050069977	Oryctes rhinoceros	Antimicrobial	US 2005/0069977 A1	Patent Application	2005##3##31	"DE60219340D1, DE60219340T2, EP1443054A1, EP1443054A4, EP1443054B1, US7041808, WO2003033532A1"	"Antimicrobial proteins, genes encoding the proteins and method of using the same."	"It is intended to provide thermotolerant and antimicrobial proteins having a broad antibacterial spectrum and being useful in the agricultural, medical and industrial field; and plants resistant to pathogenic microorganisms. Namely, DNAs comprising the base sequences represented by SEQ ID NOS: 1 to 5 respectively; antimicrobial proteins encoded by these DNAs; and fungicides, antibacterial agents and antibacterial/antifungal agents for industrial use comprising the antimicrobial proteins as the active ingredient."
DRAMP05419	RLLRKWWWKRLL	12	Sequence 1 from Patent US 20050171335	Synthetic construct	Antimicrobial	US 2005/0171335 A1	Patent Application	2005##8##4	US7176276	Novel antimicrobial peptide and use thereof.	"An object of the invention is to provide an antimicrobial peptide having an amino acid sequence which is different from a peptide existing and functioning as an antimicrobial peptide in the natural world and is not based on the conventional developmental approach for an antimicrobial peptide-containing antimicrobial agent, and a polynucleotide coding for said peptide. Another object is to provide an antimicrobial agent which contains such an antimicrobial peptide. Namely, an antimicrobial peptide represented by a general formula (1) (Xa)n-S (1) wherein Xa of the formula (1) is a hydrophilic amino acid residue, n is an integer of from 1 to 6, two or more of the Xa may be the same or different from one another, S is a peptide represented by hydrophobic amino acid part-basic amino acid part-bridge part-basic amino acid part-hydrophobic amino acid part, and amino acid residue of the bridge part is selected from the group consisting of hydrophobic amino acids and neutral amino acids."
DRAMP05420	RRLLRKWWWKRLL	13	Sequence 2 from Patent US 20050171335	Synthetic construct	Antimicrobial	US 2005/0171335 A1	Patent Application	2005##8##4	US7176276	Novel antimicrobial peptide and use thereof.	"An object of the invention is to provide an antimicrobial peptide having an amino acid sequence which is different from a peptide existing and functioning as an antimicrobial peptide in the natural world and is not based on the conventional developmental approach for an antimicrobial peptide-containing antimicrobial agent, and a polynucleotide coding for said peptide. Another object is to provide an antimicrobial agent which contains such an antimicrobial peptide. Namely, an antimicrobial peptide represented by a general formula (1) (Xa)n-S (1) wherein Xa of the formula (1) is a hydrophilic amino acid residue, n is an integer of from 1 to 6, two or more of the Xa may be the same or different from one another, S is a peptide represented by hydrophobic amino acid part-basic amino acid part-bridge part-basic amino acid part-hydrophobic amino acid part, and amino acid residue of the bridge part is selected from the group consisting of hydrophobic amino acids and neutral amino acids."
DRAMP05421	RRRLLRKWWWKRLL	14	Sequence 3 from Patent US 20050171335	Synthetic construct	Antimicrobial	US 2005/0171335 A1	Patent Application	2005##8##4	US7176276	Novel antimicrobial peptide and use thereof.	"An object of the invention is to provide an antimicrobial peptide having an amino acid sequence which is different from a peptide existing and functioning as an antimicrobial peptide in the natural world and is not based on the conventional developmental approach for an antimicrobial peptide-containing antimicrobial agent, and a polynucleotide coding for said peptide. Another object is to provide an antimicrobial agent which contains such an antimicrobial peptide. Namely, an antimicrobial peptide represented by a general formula (1) (Xa)n-S (1) wherein Xa of the formula (1) is a hydrophilic amino acid residue, n is an integer of from 1 to 6, two or more of the Xa may be the same or different from one another, S is a peptide represented by hydrophobic amino acid part-basic amino acid part-bridge part-basic amino acid part-hydrophobic amino acid part, and amino acid residue of the bridge part is selected from the group consisting of hydrophobic amino acids and neutral amino acids."
DRAMP05422	LLRKWWWKRLL	11	Sequence 4 from Patent US 20050171335	Synthetic construct	Antimicrobial	US 2005/0171335 A1	Patent Application	2005##8##4	US7176276	Novel antimicrobial peptide and use thereof.	"An object of the invention is to provide an antimicrobial peptide having an amino acid sequence which is different from a peptide existing and functioning as an antimicrobial peptide in the natural world and is not based on the conventional developmental approach for an antimicrobial peptide-containing antimicrobial agent, and a polynucleotide coding for said peptide. Another object is to provide an antimicrobial agent which contains such an antimicrobial peptide. Namely, an antimicrobial peptide represented by a general formula (1) (Xa)n-S (1) wherein Xa of the formula (1) is a hydrophilic amino acid residue, n is an integer of from 1 to 6, two or more of the Xa may be the same or different from one another, S is a peptide represented by hydrophobic amino acid part-basic amino acid part-bridge part-basic amino acid part-hydrophobic amino acid part, and amino acid residue of the bridge part is selected from the group consisting of hydrophobic amino acids and neutral amino acids."
DRAMP05423	KFAKKFAKKFAKKFAK	16	Sequence 1 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05424	KFAKKFAKKFAKKFAKKFAK	20	Sequence 2 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05425	KFAKKFAKKFAKKFAKKFAKKFAK	24	Sequence 3 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05426	KFAKKFAKKFAKKFAKKFAKKFAKKFAK	28	Sequence 4 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05427	KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK	32	Sequence 5 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05428	KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK	48	Sequence 6 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05429	KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK	68	Sequence 7 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05430	KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK	84	Sequence 8 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05431	RFARRFARRFARRFARRFARRFAR	24	Sequence 9 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05432	RFARRFARRFARRFARRFARRFARRFAR	28	Sequence 10 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05433	RFARRFARRFARRFARRFARRFARRFARRFAR	32	Sequence 11 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05434	FAKKFAKKFAKKFAKKFAKKFAKK	24	Sequence 12 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05435	AKKFAKKFAKKFAKKFAKKFAKKF	24	Sequence 13 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05436	KKFAKKFAKKFAKKFAKKFAKKFA	24	Sequence 14 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05437	LKKLLKKLLKKLLKKLLKKL	20	Sequence 15 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05438	LKKLLKKLLKKLLKKLLKKLLKKL	24	Sequence 16 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05439	LKKLLKKLLKKLLKKLLKKLLKKLLKKL	28	Sequence 17 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05440	LKKLLKKLLKKLLKKLLKKLLKKLLKKLLKKL	32	Sequence 18 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05441	KFAFKFAFKFAFKFAFKFAFKFAFKFAF	28	Sequence 19 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05442	KFFKKFFKKFFKKFFKKFFKKFFKKFFK	28	Sequence 20 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP18754	RCICRRGFC	9	Sequence 34 from Patent US 20090264344	Synthetic construct	"Antimicrobial, Antibacterial, Antiviral"	US 2009/0264344 A1	Patent Application	2009##10##22	"US7314858, US7718610, US20050272645, WO2006052637A1"	"Retrocyclins, antiviral and antimicrobial peptides."	"Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV1 retrovirus or other sexuallytransmitted pathogens."
DRAMP05444	KAAKKAAKKAAKKAAKKAAKKAAKKAAK	28	Sequence 22 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05445	KKAKKKAKKKAKKKAKKKAKKKAKKKAK	28	Sequence 23 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05446	KFKKFKKFKKFKKFK	15	Sequence 24 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05447	KFKKFKKFKKFKKFKKFK	18	Sequence 25 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05448	KFKKFKKFKKFKKFKKFKKFK	21	Sequence 26 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05449	KFKKFKKFKKFKKFKKFKKFKKFK	24	Sequence 27 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05450	KFKKFKKFKKFKKFKKFKKFKKFKKFK	27	Sequence 28 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05451	KFKKFKKFKKFKKFKKFKKFKKFKKFKKFK	30	Sequence 29 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05452	KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK	36	Sequence 30 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05453	KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK	48	Sequence 31 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05454	KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK	63	Sequence 32 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05455	FKAFKA	6	Sequence 33 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05456	FKAFKAFKAFKA	12	Sequence 34 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05457	FKAFKAFKAFKAFKAFKA	18	Sequence 35 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05458	FKAFKAFKAFKAFKAFKAFKA	21	Sequence 36 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05459	FKAFKAFKAFKAFKAFKAFKAFKA	24	Sequence 37 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05460	FKAFKAFKAFKAFKAFKAFKAFKAFKA	27	Sequence 38 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05461	FKAFKAFKAFKAFKAFKAFKAFKAFKAFKA	30	Sequence 39 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05462	FKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKA	51	Sequence 40 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05463	FKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKA	63	Sequence 41 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05464	LKLK	4	Sequence 42 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05465	LKLKLKLKLK	10	Sequence 43 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05466	LKLKLKLKLKLKLKLK	16	Sequence 44 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05467	LKLKLKLKLKLKLKLKLK	18	Sequence 45 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05468	LKLKLKLKLKLKLKLKLKLK	20	Sequence 46 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05469	LKLKLKLKLKLKLKLKLKLKLK	22	Sequence 47 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05470	LKLKLKLKLKLKLKLKLKLKLKLK	24	Sequence 48 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05471	LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK	36	Sequence 49 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05472	LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK	48	Sequence 50 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05473	LRLRLRLRLRLRLR	14	Sequence 51 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05474	LRLRLRLRLRLRLRLRLR	18	Sequence 52 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05475	LRLRLRLRLRLRLRLRLRLRLR	22	Sequence 53 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05476	KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK	33	Sequence 54 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05477	KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK	45	Sequence 55 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05478	KTKKTKKTKKTKKTKKTKKTK	21	Sequence 56 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05479	KFAK	4	Sequence 57 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05480	KFAKKFAK	8	Sequence 58 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05481	KFAKKFAKKFAK	12	Sequence 59 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05482	LKLKLKLKLKLKLK	14	Sequence 60 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05483	KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK	80	Sequence 61 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05484	KFKKFKKFK	9	Sequence 62 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05485	KFKKFKKFKKFK	12	Sequence 63 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05486	KGKKGKKGKKGKKGKKGKKGK	21	Sequence 64 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05487	FAKKFAKKFKKFAKKFAKFAFAF	23	Sequence 65 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05488	FKLRAKIKVRLRAKIKL	17	Sequence 66 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05489	KFAKKFAKKFAKKAAK	16	Sequence 67 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05490	KFAKKFAKKAAKKAAK	16	Sequence 68 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05491	KFAKKAAKKFAKKAAK	16	Sequence 69 from Patent US 7091185	Synthetic construct	Antimicrobial	US 7091185 B2	Granted Patent	2006##8##15	US20050187151	Periodic antimicrobial peptides.	"One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%."
DRAMP05492	RVVRQWPIGRVVRRVVRRVVR	21	Sequence 1 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05493	KVVKQWPIGKVVKKVVKKVVK	21	Sequence 2 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05494	RLLRQWPIGRLLRRLLRRLLR	21	Sequence 3 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05495	KLLKQWPIGKLLKKLLKKLLK	21	Sequence 4 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05496	RVLRQWPIGRVLRRVLRRVLR	21	Sequence 5 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05497	KVLKQWPIGKVLKKVLKKVLK	21	Sequence 6 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05498	RLVRQWPIGRLVRRLVRRLVR	21	Sequence 7 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05499	KLVKQWPIGKLVKKLVKKLVK	21	Sequence 8 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05500	RVVKQWPIGRVVKRVVKRVVK	21	Sequence 9 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05501	KVVRQWPIGKVVRKVVRKVVR	21	Sequence 10 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05502	RLLKQWPIGRLLKRLLKRLLK	21	Sequence 11 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05503	KLLRQWPIGKLLRKLLRKLLR	21	Sequence 12 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05504	RVLKQWPIGRVLKRVLKRVLK	21	Sequence 13 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05505	KVLRQWPIGKVLRKVLRKVLR	21	Sequence 14 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05506	RLVKQWPIGRLVKRLVKRLVK	21	Sequence 15 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05507	KLVRQWPIGKLVRKLVRKLVR	21	Sequence 16 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05508	KLVRQFPVGKLVRKLVRKLVR	21	Sequence 17 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05509	RVVRNWPIGRVVRRVVRRVVR	21	Sequence 18 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP05510	KVVKNWPIGKVVKKVVKKVVK	21	Sequence 19 from Patent US 20050215481	Synthetic construct	Antimicrobial	US 2005/0215481 A1	Patent Application	2005##9##29	"US7348402, WO2003080652A1"	"Antimicrobial peptide, its analogs and antimicrobial composition comprising them."	"Disclosed is a novel antimicrobial peptide having excellent antimicrobial activities, its analogs and an antimicrobial composition comprising them. The antimicrobial peptide alternatively comprises basic amino acid residues and hydrophobic amino acid residues, and is able to penetrate into microbial cells and act against a wide variety of microorganisms."
DRAMP10738	KRWKHIRRI	9	Sequence 764 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10739	WIVWIRKRI	9	Sequence 765 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10740	RRWVIRIYK	9	Sequence 766 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10741	WFWRRKMIR	9	Sequence 767 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10742	RYRRWVRKR	9	Sequence 768 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10743	RKWWWKWRR	9	Sequence 769 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10744	RIWMFKIFR	9	Sequence 770 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10745	IVRVGIFRL	9	Sequence 771 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10746	IIRLIKWWR	9	Sequence 772 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10747	WVRRYQMRR	9	Sequence 773 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10748	WQVVMRYRR	9	Sequence 774 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10749	KKWKVWRFG	9	Sequence 775 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10750	WRYWWTRRI	9	Sequence 776 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10751	RIRKGWKWG	9	Sequence 777 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10752	KKRRGNRVR	9	Sequence 778 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10753	VMRKLRRRW	9	Sequence 779 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10754	RNRTHWWRK	9	Sequence 780 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10755	RFTWWWRKF	9	Sequence 781 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10756	KRIRYKRWH	9	Sequence 782 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10757	RWRRYGRVY	9	Sequence 783 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10758	TVVKKRVKK	9	Sequence 784 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10759	RKYRRRYRR	9	Sequence 785 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10760	YFRWWKRWI	9	Sequence 786 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10761	WWQWIVWRK	9	Sequence 787 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10762	RKRLYRWIK	9	Sequence 788 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10763	GWWKNWRWW	9	Sequence 789 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10764	KWWWYWYRR	9	Sequence 790 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10765	RFKWFIRRF	9	Sequence 791 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10766	RIRRLWNIV	9	Sequence 792 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10767	ARWMWRRWR	9	Sequence 793 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10768	LVRWVWGKR	9	Sequence 794 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10769	KRWLKWWRV	9	Sequence 795 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10770	FVYRGWRRK	9	Sequence 796 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10771	RRRWKIYKW	9	Sequence 797 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10772	KRWWQWRWF	9	Sequence 798 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10773	KRVKVRWVT	9	Sequence 799 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10774	RFKYWRWWQ	9	Sequence 800 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10775	KRQWWRVFK	9	Sequence 801 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10776	FKIVWWRRR	9	Sequence 802 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10777	QWWWKYRWK	9	Sequence 803 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10778	RWLRIRKVY	9	Sequence 804 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10779	RYKRVVYRH	9	Sequence 805 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10780	KVRWKWWGW	9	Sequence 806 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10781	IWKVRIFKR	9	Sequence 807 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10782	AIWHKTRRL	9	Sequence 808 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10783	IRQRVRWRW	9	Sequence 809 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10784	MKVWIRWRI	9	Sequence 810 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10785	QRRWWGRFK	9	Sequence 811 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10786	NKRVWFIYR	9	Sequence 812 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10787	RVVNWKGGL	9	Sequence 813 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10788	RYRRFRVRW	9	Sequence 814 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10789	KKVRRVIWW	9	Sequence 815 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10790	WFTRWKWRW	9	Sequence 816 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10791	KWVWFRWRK	9	Sequence 817 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10792	KYLRSVIFY	9	Sequence 818 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10793	FKRSWVQIV	9	Sequence 819 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10794	RWWFIRKWW	9	Sequence 820 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10795	IRRWKRVWW	9	Sequence 821 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10796	QKWYRQRRN	9	Sequence 822 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10797	VWRKWYRVK	9	Sequence 823 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10798	KKKLWRKFR	9	Sequence 824 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10799	RRWWWWRFN	9	Sequence 825 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10800	WFFKSKVYW	9	Sequence 826 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10801	RVVNLNWRW	9	Sequence 827 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10802	RWRRNWMTK	9	Sequence 828 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10803	WKIWKIRWF	9	Sequence 829 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10804	WWFWVIRKY	9	Sequence 830 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10805	RYVKIRWVR	9	Sequence 831 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10806	RIWILSWRW	9	Sequence 832 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10807	KSWRKLFIW	9	Sequence 833 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10808	VWVRWKIWY	9	Sequence 834 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10809	KKRRFKRRY	9	Sequence 835 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10810	RFWKKIRRH	9	Sequence 836 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10811	RKVWWRVFY	9	Sequence 837 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10812	YWRRKWRRK	9	Sequence 838 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10813	KRIRRWKWW	9	Sequence 839 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10814	YWRYLWIRF	9	Sequence 840 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10815	IIYKWRWYW	9	Sequence 841 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10816	QTVYLIFRR	9	Sequence 842 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10817	AKKIKWLVW	9	Sequence 843 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10818	YRFVRRWIV	9	Sequence 844 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10819	VWRRYWWYR	9	Sequence 845 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10820	ARKWKYWRF	9	Sequence 846 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10821	RKRVIKRWR	9	Sequence 847 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10822	RSFWWMWFK	9	Sequence 848 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10823	WRINIFKRI	9	Sequence 849 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10824	RWRVLKRRK	9	Sequence 850 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10825	RWWVIWWWK	9	Sequence 851 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10826	KLIRIWWWW	9	Sequence 852 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10827	FKRKRWWGI	9	Sequence 853 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10828	VWHWWRWRW	9	Sequence 854 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10829	WKRWLIIGR	9	Sequence 855 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10830	AYRWWTRFK	9	Sequence 856 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10831	SWWWIWLKK	9	Sequence 857 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10832	FVIWKYIRV	9	Sequence 858 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10833	RWVRTRRRR	9	Sequence 859 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10834	RRSWWYKRR	9	Sequence 860 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10835	RKYVWWKSI	9	Sequence 861 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10836	WWKRYIVKK	9	Sequence 862 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10837	WFIRVWRYR	9	Sequence 863 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10838	WKMWLRKHW	9	Sequence 864 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10839	RRFFWKKGI	9	Sequence 865 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10840	KRWTFWSRR	9	Sequence 866 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10841	AVQRWRWVV	9	Sequence 867 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10842	IWKYGWRYK	9	Sequence 868 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10843	IIKWWRRWR	9	Sequence 869 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10844	AFRKVKRWG	9	Sequence 870 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10845	MGFTRKWQF	9	Sequence 871 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10846	NWIRWRKWR	9	Sequence 872 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10847	RIGRKLRIR	9	Sequence 873 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10848	RWWRWRHVI	9	Sequence 874 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10849	RLVSKRRRK	9	Sequence 875 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10850	RRKYWKKYR	9	Sequence 876 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10851	IILWWYRRK	9	Sequence 877 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10852	IYFWWWRIR	9	Sequence 878 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10853	HKRKWWRFR	9	Sequence 879 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10854	IGRFWRRWL	9	Sequence 880 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10855	RIRRVLVYV	9	Sequence 881 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10856	WWLRGRRWL	9	Sequence 882 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10857	VRIRKRRWR	9	Sequence 883 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10858	WWRRKWWRR	9	Sequence 884 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10859	WWWRSFRKR	9	Sequence 885 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10860	VGQKWRKRT	9	Sequence 886 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10861	FRRRYRVYR	9	Sequence 887 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10862	RIRRKRKGR	9	Sequence 888 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10863	WKWVTRMYI	9	Sequence 889 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10864	KVVRKKRLR	9	Sequence 890 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10865	RKRRKHWRY	9	Sequence 891 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10866	RVTRTWQRW	9	Sequence 892 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10867	RRRITRKRI	9	Sequence 893 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10868	RLILIKKKW	9	Sequence 894 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10869	WKRRWSRSR	9	Sequence 895 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10870	MWWWFLWRR	9	Sequence 896 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10871	RWVRIWKKK	9	Sequence 897 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10872	KRRVWRMWR	9	Sequence 898 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10873	WHWWIRWWR	9	Sequence 899 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10874	WWRRLRWLV	9	Sequence 900 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10875	KWWIWKRRR	9	Sequence 901 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10876	RYGRKWMIW	9	Sequence 902 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10877	RVKKIKLFI	9	Sequence 903 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10878	RIRYIQRVW	9	Sequence 904 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10879	RLIRWWRKR	9	Sequence 905 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10880	QRGRWLRRG	9	Sequence 906 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10881	RRRRWIRKK	9	Sequence 907 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10882	LGRRWRYRR	9	Sequence 908 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10883	FKIVHVKVR	9	Sequence 909 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10884	FRKKYRVRR	9	Sequence 910 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10885	WKYKYRIRL	9	Sequence 911 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10886	HVRRWWRII	9	Sequence 912 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10887	RFKWWRRYW	9	Sequence 913 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10888	RRRRMRKKI	9	Sequence 914 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10889	RRIRGRVGR	9	Sequence 915 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10890	AFWRWIRFK	9	Sequence 916 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10891	VKKRKIVIY	9	Sequence 917 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10892	KRVKWTWRK	9	Sequence 918 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10893	TGVGRGYRI	9	Sequence 919 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10894	LSWKWWRRV	9	Sequence 920 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10895	IKTFIKRWR	9	Sequence 921 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10896	KMRLKWKRR	9	Sequence 922 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10897	WRWYVTRRK	9	Sequence 923 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10898	IYRRRRKLR	9	Sequence 924 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10899	VWWKWWRWW	9	Sequence 925 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10900	KYKKGWRVV	9	Sequence 926 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10901	KWRRWYYWR	9	Sequence 927 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10902	RRWVFGRRY	9	Sequence 928 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10903	GFTWKKKRR	9	Sequence 929 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10904	YKKIRIKRR	9	Sequence 930 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10905	VWIRRIKRR	9	Sequence 931 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10906	WWKWIRKIV	9	Sequence 932 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10907	WRRKWWSRW	9	Sequence 933 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10908	VTRRRTRIK	9	Sequence 934 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10909	RKRWFVYIW	9	Sequence 935 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10910	IIKWKRIMI	9	Sequence 936 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10911	FNRWWWKKI	9	Sequence 937 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10912	RYKSRRVRR	9	Sequence 938 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10913	VKVIKKFVR	9	Sequence 939 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10914	KWKWLQGRR	9	Sequence 940 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10915	KVRWWYNIK	9	Sequence 941 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10916	FWFRIRKLK	9	Sequence 942 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10917	KRRKQRKYR	9	Sequence 943 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10918	AKNSKRRLW	9	Sequence 944 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10919	RNRRIFRYS	9	Sequence 945 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10920	RWTKWFLVR	9	Sequence 946 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10921	RIRRTRRTR	9	Sequence 947 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10922	KIRWWRISI	9	Sequence 948 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10923	YKGRWGRRW	9	Sequence 949 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10924	MYYRIKQKW	9	Sequence 950 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10925	WRIQRWRWQ	9	Sequence 951 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10926	IRRWSYRRW	9	Sequence 952 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10927	VRIWKIIWW	9	Sequence 953 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10928	RWRWWWLWK	9	Sequence 954 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10929	TKRRWIWIT	9	Sequence 955 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10930	RRWHYWKGW	9	Sequence 956 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10931	WRIRKWWMR	9	Sequence 957 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10932	KRRTRWWVR	9	Sequence 958 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10933	RKWRVWKRR	9	Sequence 959 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10934	WRVWKIRVR	9	Sequence 960 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10935	KYWGIGGWR	9	Sequence 961 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10936	RLISRRRKK	9	Sequence 962 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10937	VSRRIVRRM	9	Sequence 963 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10938	ITKWWRKRR	9	Sequence 964 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10939	KWKIQLWKI	9	Sequence 965 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10940	KKWTWWYVI	9	Sequence 966 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10941	SWKKNRKIW	9	Sequence 967 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10942	HKRQYRKWF	9	Sequence 968 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10943	IFKWFYRRK	9	Sequence 969 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10944	ILKWKWPWWKWRR	13	Sequence 973 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10945	ILPWKWRWWKWRR	13	Sequence 974 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10946	FLPKKFRWWKYRK	13	Sequence 975 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10947	FIKWKFRWWKWRK	13	Sequence 976 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10948	KWPWWPWRR	9	Sequence 977 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10949	KWPWWPWRK	9	Sequence 978 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10950	KFPWWPWRR	9	Sequence 979 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10951	KKPWWPWRR	9	Sequence 980 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10952	KWRWWPWRR	9	Sequence 981 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10953	KWPKWPWRR	9	Sequence 982 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10954	KWPWKPWRR	9	Sequence 983 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10955	KWPWWKWRR	9	Sequence 984 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10956	KWPWWPKRR	9	Sequence 985 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10957	KFRWWPWRR	9	Sequence 987 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10958	KFRWWKWRR	9	Sequence 988 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10959	KWRWWKKRR	9	Sequence 989 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10960	KKKWWKWRR	9	Sequence 990 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10961	KFHWWIWRK	9	Sequence 991 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10962	KFHWWKWRK	9	Sequence 992 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10963	KFKWWKYRK	9	Sequence 993 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10964	KFKFFKYRK	9	Sequence 994 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10965	KFKFFKFRK	9	Sequence 995 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10966	PWWPWRR	7	Sequence 996 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10967	KWWPWRR	7	Sequence 997 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10968	RWWPWRR	7	Sequence 999 from Patent US 20110236429	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10969	PKWPWRR	7	Sequence 1000 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10970	PWKPWRR	7	Sequence 1001 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10971	PWWPKRR	7	Sequence 1003 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10972	PWWPWRK	7	Sequence 1004 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10973	RWWKWRR	7	Sequence 1005 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10974	RWWKWRK	7	Sequence 1006 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10975	RFWKWRR	7	Sequence 1007 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10976	RWWIKRR	7	Sequence 1008 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10977	RWWIYRR	7	Sequence 1009 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10978	RFFKFRR	7	Sequence 1010 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10979	KWWKWKK	7	Sequence 1011 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10980	KFFKFKK	7	Sequence 1012 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10981	RWRWKRWWW	9	Sequence 1013 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10982	RWRRWKWWW	9	Sequence 1014 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10983	RWWRWRKWW	9	Sequence 1015 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10984	RWRRKWWWW	9	Sequence 1016 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10985	RWRWWKRWY	9	Sequence 1017 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10986	RRKRWWWWW	9	Sequence 1018 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10987	RWRIKRWWW	9	Sequence 1019 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10988	KIWWWWRKR	9	Sequence 1020 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10989	RWRRWKWWL	9	Sequence 1021 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10990	KRWWKWIRW	9	Sequence 1022 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10991	KRWWWWWKR	9	Sequence 1023 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10992	IRWWKRWWR	9	Sequence 1024 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10993	IKRWWRWWR	9	Sequence 1025 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10994	RRKWWWRWW	9	Sequence 1026 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10995	RKWWRWWRW	9	Sequence 1027 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10996	KRWWWWRFR	9	Sequence 1028 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10997	IKRWWWRRW	9	Sequence 1029 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10998	KRWWWVWKR	9	Sequence 1030 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP10999	KWRRWKRWW	9	Sequence 1031 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11000	WRWWKIWKR	9	Sequence 1032 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11001	WRWRWWKRW	9	Sequence 1033 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11002	WKRWKWWKR	9	Sequence 1034 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11003	RIKRWWWWR	9	Sequence 1035 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11004	IWKRWWRRW	9	Sequence 1036 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11005	KWWKIWWKR	9	Sequence 1037 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11006	RKRWLWRWW	9	Sequence 1038 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11007	KRWRWWRWW	9	Sequence 1039 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11008	KKRWLWWWR	9	Sequence 1040 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11009	RWWRKWWIR	9	Sequence 1041 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11010	KWWRWWRKW	9	Sequence 1042 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11011	KRWWIRWWR	9	Sequence 1043 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11012	KIWWWWRRR	9	Sequence 1044 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11013	RRRKWWIWW	9	Sequence 1045 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11014	RRRWWWWWW	9	Sequence 1046 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11015	RWWIRKWWR	9	Sequence 1047 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11016	KRWWKWWRR	9	Sequence 1048 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11017	KRWWRKWWR	9	Sequence 1049 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11018	RRIWRWWWW	9	Sequence 1050 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11019	IRRRKWWWW	9	Sequence 1051 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11020	KRKIWWWIR	9	Sequence 1052 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11021	RKIWWWRIR	9	Sequence 1053 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11022	KRWWIWRIR	9	Sequence 1054 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11023	RWFRWWKRW	9	Sequence 1055 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11024	WRWWWKKWR	9	Sequence 1056 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11025	WKRWWKKWR	9	Sequence 1057 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11026	WKRWRWIRW	9	Sequence 1058 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11027	WRWWKWWRR	9	Sequence 1059 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11028	WKKWWKRRW	9	Sequence 1060 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11029	WRWYWWKKR	9	Sequence 1061 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11030	WRRWWKWWR	9	Sequence 1062 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11031	IRMWVKRWR	9	Sequence 1063 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11032	RIWYWYKRW	9	Sequence 1064 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11033	FRRWWKWFK	9	Sequence 1065 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11034	RVRWWKKRW	9	Sequence 1066 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11035	RLKKVRWWW	9	Sequence 1067 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11036	RWWLKIRKW	9	Sequence 1068 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11037	LRWWWIKRI	9	Sequence 1069 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11038	TRKVWWWRW	9	Sequence 1070 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11039	KRFWIWFWR	9	Sequence 1071 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11040	KKRWVWVIR	9	Sequence 1072 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11041	KRWVWYRYW	9	Sequence 1073 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11042	IRKWRRWWK	9	Sequence 1074 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11043	RHWKTWWKR	9	Sequence 1075 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11044	RRFKKWYWY	9	Sequence 1076 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11045	RIKVIWWWR	9	Sequence 1077 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11046	RKRLKWWIY	9	Sequence 1078 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11047	LVFRKYWKR	9	Sequence 1079 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11048	RRRWWWIIV	9	Sequence 1080 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11049	KKRWVWIRY	9	Sequence 1081 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11050	RWRIKFKRW	9	Sequence 1082 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11051	KWKIFRRWW	9	Sequence 1083 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11052	IWKRWRKRL	9	Sequence 1084 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11053	RRRKWWIWG	9	Sequence 1085 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11054	RWLVLRKRW	9	Sequence 1086 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11055	RKWIWRWFL	9	Sequence 1087 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11056	KRRRIWWWK	9	Sequence 1088 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11057	IWWKWRRWV	9	Sequence 1089 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11058	LRWRWWKIK	9	Sequence 1090 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11059	RWKMWWRWV	9	Sequence 1091 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11060	VKRYYWRWR	9	Sequence 1092 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11061	RWYRKRWSW	9	Sequence 1093 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11062	KRKLIRWWW	9	Sequence 1094 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11063	RWRWWIKII	9	Sequence 1095 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11064	KFRKRVWWW	9	Sequence 1096 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11065	IWIWRKLRW	9	Sequence 1097 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11066	LRFILWWKR	9	Sequence 1098 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11067	RVWFKRRWW	9	Sequence 1099 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11068	RRWFVKWWY	9	Sequence 1100 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11069	KWWLVWKRK	9	Sequence 1101 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11070	RWILWWWRI	9	Sequence 1102 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11071	KRWLTWRFR	9	Sequence 1103 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11072	RKWRWRWLK	9	Sequence 1104 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11073	IRRRWWWIV	9	Sequence 1105 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11074	IKWWWRMRI	9	Sequence 1106 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11075	RWKIFIRWW	9	Sequence 1107 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11076	IRQWWRRWW	9	Sequence 1108 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11077	RRRKTWYWW	9	Sequence 1109 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11078	RRWWMRWWV	9	Sequence 1110 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11079	RRFKFIRWW	9	Sequence 1112 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11080	INRKRRLRW	9	Sequence 1113 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11081	RRMKKLRRK	9	Sequence 1114 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11082	RKVRWKIRV	9	Sequence 1115 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11083	VRIVRVRIR	9	Sequence 1116 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11084	IKRVKRRKR	9	Sequence 1117 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11085	RVKTWRVRT	9	Sequence 1118 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11086	RVFVKIRMK	9	Sequence 1119 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11087	IRGRIIFWV	9	Sequence 1120 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11088	ATWIWVFRR	9	Sequence 1121 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11089	KKSKQLWKR	9	Sequence 1122 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11090	MINRVRLRW	9	Sequence 1123 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11091	GGIRRLRWY	9	Sequence 1124 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11092	RLVHWIRRV	9	Sequence 1125 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11093	AWKIKKGRI	9	Sequence 1126 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11094	FVVMKRIVW	9	Sequence 1127 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11095	GIKWRSRRW	9	Sequence 1128 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11096	RWMVSKIWY	9	Sequence 1129 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11097	IVVRVWVVR	9	Sequence 1130 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11098	RWIGVIIKY	9	Sequence 1131 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11099	WIRKRSRIF	9	Sequence 1132 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11100	GWKILRKRK	9	Sequence 1133 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11101	YQRLFVRIR	9	Sequence 1134 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11102	AVWKFVKRV	9	Sequence 1135 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11103	IRKKRRRWT	9	Sequence 1136 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11104	ILRVISKRR	9	Sequence 1137 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11105	AWRFKNIRK	9	Sequence 1138 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11106	HYKFQRWIK	9	Sequence 1139 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11107	RRIRRVRWG	9	Sequence 1140 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11108	VLVKKRRRR	9	Sequence 1141 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11109	RWRGIVHIR	9	Sequence 1142 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11110	WRNRKVVWR	9	Sequence 1143 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11111	KFWWWNYLK	9	Sequence 1144 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11112	KRIMKLKMR	9	Sequence 1145 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11113	IRRRKKRIK	9	Sequence 1146 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11114	RKWMGRFLM	9	Sequence 1147 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11115	RRVQRGKWW	9	Sequence 1148 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11116	WHGVRWWKW	9	Sequence 1149 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11117	WVRFVYRYW	9	Sequence 1150 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11118	RKRTKVTWI	9	Sequence 1151 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11119	IRRIVRRKI	9	Sequence 1152 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11120	KIRRKVRWG	9	Sequence 1153 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11121	AIRRWRIRK	9	Sequence 1154 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11122	WRFKVLRQR	9	Sequence 1155 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11123	RSGKKRWRR	9	Sequence 1156 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11124	FMWVYRYKK	9	Sequence 1157 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11125	RGKYIRWRK	9	Sequence 1158 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11126	WVKVWKYTW	9	Sequence 1159 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11127	VVLKIVRRF	9	Sequence 1160 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11128	GKFYKVWVR	9	Sequence 1161 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11129	SWYRTRKRV	9	Sequence 1162 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11130	KNRGRWFSH	9	Sequence 1163 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11131	AFRGSRHRM	9	Sequence 1164 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11132	GRNGWYRIN	9	Sequence 1165 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11133	AGGMRKRTR	9	Sequence 1166 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11134	ATRKGYSKF	9	Sequence 1167 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11135	SSGVRWSWR	9	Sequence 1168 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11136	RVWRNGYSR	9	Sequence 1169 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11137	WGRTRWSSR	9	Sequence 1170 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11138	GKRVWGRGR	9	Sequence 1171 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11139	SFNWKRSGK	9	Sequence 1172 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11140	WGRGGWTNR	9	Sequence 1173 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11141	ANRWGRGIR	9	Sequence 1174 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11142	WGGHKRRGW	9	Sequence 1175 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11143	WHGGQKWRK	9	Sequence 1176 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11144	FVWQKGTNR	9	Sequence 1177 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11145	HGVWGNRKR	9	Sequence 1178 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11146	TRGWSLGTR	9	Sequence 1179 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11147	GRRVMNQKR	9	Sequence 1180 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11148	RNKFGGNWR	9	Sequence 1181 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11149	GVRVQRNSK	9	Sequence 1182 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11150	NQKWSGRRR	9	Sequence 1183 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11151	RQNGVWRVF	9	Sequence 1184 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11152	GRMRLWNGR	9	Sequence 1185 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11153	WHYRSQVGR	9	Sequence 1186 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11154	GWNTMGRRW	9	Sequence 1187 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11155	RRMGNGGFR	9	Sequence 1188 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11156	SKNVRTWRQ	9	Sequence 1189 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11157	ARGRWINGR	9	Sequence 1190 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11158	GSRRSVWVF	9	Sequence 1191 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11159	WSQNVRTRI	9	Sequence 1192 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11160	GMRRWRGKN	9	Sequence 1193 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11161	RGRTSNWKM	9	Sequence 1194 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11162	WGKRRGWNT	9	Sequence 1195 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11163	AMLGGRQWR	9	Sequence 1197 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11164	QRNKGLRHH	9	Sequence 1198 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11165	ARGKSIKNR	9	Sequence 1199 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11166	NRRNGQMRR	9	Sequence 1200 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11167	RGRRQIGKF	9	Sequence 1201 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11168	ASKRVGVRN	9	Sequence 1202 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11169	GRIGGKNVR	9	Sequence 1203 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11170	NKTGYRWRN	9	Sequence 1204 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11171	VSGNWRGSR	9	Sequence 1205 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11172	GWGGKRRNF	9	Sequence 1206 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11173	KNNRRWQGR	9	Sequence 1207 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11174	GRTMGNGRW	9	Sequence 1208 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11175	GRQISWGRT	9	Sequence 1209 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11176	GGRGTRWHG	9	Sequence 1210 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11177	GVRSWSQRT	9	Sequence 1211 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11178	GSRRFGWNR	9	Sequence 1212 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11179	LVRAIQVRAVIR	12	Sequence 1213 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11180	VQRWLIVWRIRK	12	Sequence 1214 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11181	IVWKIKRWWVGR	12	Sequence 1215 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11182	RFWKVRVKYIRF	12	Sequence 1216 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11183	VQLRIRVAV	9	Sequence 1217 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11184	VQLRIWVRR	9	Sequence 1218 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11185	WNRVKWIRR	9	Sequence 1219 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11186	RIKWIVRFR	9	Sequence 1220 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11187	AIRVVRARLVRR	12	Sequence 1221 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11188	IRWRIRVWVRRI	12	Sequence 1222 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11189	RRWVVWRIVQRR	12	Sequence 1223 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11190	IFWRRIVIVKKF	12	Sequence 1224 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11191	VRLRIRVAV	9	Sequence 1225 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11192	RQVIVRRW	8	Sequence 1226 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11193	VLIRWNGKK	9	Sequence 1227 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11194	LRIRWIFKR	9	Sequence 1228 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11195	KRIVRRLVARIV	12	Sequence 1229 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11196	VRLIVAVRIWRR	12	Sequence 1230 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11197	IVVWRRQLVKNK	12	Sequence 1231 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11198	VRLRIRWWVLRK	12	Sequence 1232 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11199	LRIRVIVWR	9	Sequence 1234 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11200	IRVWVLRQR	9	Sequence 1235 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11201	RIRVIVLKK	9	Sequence 1236 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11202	RRIVKKFQIVRR	12	Sequence 1237 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11203	VQWRIRVRVIKK	12	Sequence 1238 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11204	KKQVSRVKVWRK	12	Sequence 1239 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11205	LIQRIRVRNIVK	12	Sequence 1240 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11206	KQFRIRVRV	9	Sequence 1241 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11207	FRIRVRVIR	9	Sequence 1242 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11208	WRWRVRVWR	9	Sequence 1243 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11209	IRVRVIWRK	9	Sequence 1244 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11210	RRVIVKKFRIRR	12	Sequence 1245 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11211	KQFRNRLRIVKK	12	Sequence 1246 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11212	KRWRWIVRNIRR	12	Sequence 1247 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11213	VQFRIRVIVIRK	12	Sequence 1248 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11214	KRFRIRVRV	9	Sequence 1249 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11215	IVVRRVIRK	9	Sequence 1250 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11216	IWVIRRVWR	9	Sequence 1251 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11217	FQVVKIKVR	9	Sequence 1252 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11218	VIWIRWR	7	Sequence 1253 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11219	IVWIWRR	7	Sequence 1254 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11220	WIVIWRR	7	Sequence 1255 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11221	RRWIVWI	7	Sequence 1256 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11222	RWWRIVI	7	Sequence 1257 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11223	WIRVIRW	7	Sequence 1258 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11224	IIRRWWV	7	Sequence 1259 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11225	IRWVIRW	7	Sequence 1260 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11226	ILRWKWRWWRWRR	13	Sequence 1261 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11227	RWRWWRWRR	9	Sequence 1262 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11228	KWKWWKWKK	9	Sequence 1263 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11229	RWWRWRR	7	Sequence 1264 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11230	RIRVAV	6	Sequence 1265 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11231	WKWPWWPW	8	Sequence 1266 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11232	KIWVIRWWR	9	Sequence 1267 from Patent US 2011023642	Synthetic construct	Antimicrobial	US 2011/0236429 A1	Patent Application	2011##9##29	"CA2660668A1, EP2061886A4, US8343475, US20110236429, WO2008022444A1"	Small Cationic Antimicrobial Peptides.	The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.
DRAMP11233	FFWLIKGAIHAGKAIHGLIHRRRH	24	Sequence 1 from Patent US 20110269669	Chrysophrys major	Antimicrobial	US 2011/0269669 A1	Patent Application	2011##11##3	US8394762	Self-decontaminating coatings containing antimicrobial peptides.	"Disclosed herein is a composition having: a polymeric material and an antimicrobial peptide derived from Chrysophrys major. Also disclosed herein is a method of: combining the polymeric material and antimicrobial peptide to form a coating material, and applying the coating material to a surface."
DRAMP11234	FFWLIKGAIHAGKAIHGLIH	20	Sequence 2 from Patent US 20110269669	Chrysophrys major	Antimicrobial	US 2011/0269669 A1	Patent Application	2011##11##3	US8394762	Self-decontaminating coatings containing antimicrobial peptides.	"Disclosed herein is a composition having: a polymeric material and an antimicrobial peptide derived from Chrysophrys major. Also disclosed herein is a method of: combining the polymeric material and antimicrobial peptide to form a coating material, and applying the coating material to a surface."
DRAMP11235	FIGLLISAGKAIHDLIRRRH	20	Sequence 3 from Patent US 20110269669	Chrysophrys major	Antimicrobial	US 2011/0269669 A1	Patent Application	2011##11##3	US8394762	Self-decontaminating coatings containing antimicrobial peptides.	"Disclosed herein is a composition having: a polymeric material and an antimicrobial peptide derived from Chrysophrys major. Also disclosed herein is a method of: combining the polymeric material and antimicrobial peptide to form a coating material, and applying the coating material to a surface."
DRAMP11236	FIGLLISAGKAIHDLI	16	Sequence 4 from Patent US 20110269669	Chrysophrys major	Antimicrobial	US 2011/0269669 A1	Patent Application	2011##11##3	US8394762	Self-decontaminating coatings containing antimicrobial peptides.	"Disclosed herein is a composition having: a polymeric material and an antimicrobial peptide derived from Chrysophrys major. Also disclosed herein is a method of: combining the polymeric material and antimicrobial peptide to form a coating material, and applying the coating material to a surface."
DRAMP11237	KRRLIARILRLAARALVKKR	20	Sequence 1 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11238	KRKLIFLAAFLAALALFKKR	20	Sequence 2 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11239	KRRLAAFRAFRGALKSVLKK	20	Sequence 3 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11240	KRRLIARILRLAIRALVKKR	20	Sequence 4 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11241	KRRLILRILRLAIRALVKKR	20	Sequence 5 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11242	KRRLILRILRLAIRILVKKR	20	Sequence 6 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11243	KRRLIFRILKLFFRFLVKKR	20	Sequence 7 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11244	KRRILIRILKLIIKLILKKR	20	Sequence 8 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11245	KRRKLIKILKLIIKLIRKKR	20	Sequence 9 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11246	KRRKLIKILKLIAKLIRKKR	20	Sequence 10 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11247	KRRKAIKILKLIAKLIRKKR	20	Sequence 11 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11248	KRRKAIKILKLIAKAIRKKR	20	Sequence 12 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11249	KRRLALFRAFRLALKSVLKK	20	Sequence 13 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11250	KRRLALFRLFRLALKLVLKK	20	Sequence 14 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11251	KRRLFLFRLFRLFLRLFLKK	20	Sequence 15 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11252	KRRKLAFRAFRFALKAVLKK	20	Sequence 16 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11253	KRRKLAFRLFRLFLKLVLKK	20	Sequence 17 from Patent US 20110294721	Synthetic construct	Antimicrobial	US 2011/0294721 A1	Patent Application	2011##12##1	"EP2168590A1, EP2341920A1, WO2010034786A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid resi"
DRAMP11254	RKKRLKLLKRLV	12	Sequence 1 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11255	RKKRLKLLKRLL	12	Sequence 2 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11256	RKKRVKLLKRLV	12	Sequence 3 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11257	RKKKVKLLKRLV	12	Sequence 4 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11258	RKKRLKVVKRLV	12	Sequence 5 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11259	RKKRLRVVRRLV	12	Sequence 6 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11260	RKKKLKVVKRLV	12	Sequence 7 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11261	RKKKLKIIKRLI	12	Sequence 8 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11262	RKKKIKIIKRLI	12	Sequence 9 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11263	RKKKIKIIKKII	12	Sequence 10 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11264	RKKKAKIIKKII	12	Sequence 11 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11265	RKKKLKFFKRLF	12	Sequence 12 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11266	RKKKFKFFKRLF	12	Sequence 13 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11267	RKKKFKFFKRFF	12	Sequence 14 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11268	RKKKFKIFKRLF	12	Sequence 15 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11269	KRKKLLKRLL	10	Sequence 16 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11270	KRKKLLKRLI	10	Sequence 17 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11271	KKKKIIKRLI	10	Sequence 18 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11272	RKKRKKLLKRLL	12	Sequence 19 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11273	RKKRKKLIKRLI	12	Sequence 20 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11274	RKKRKKLLKRLI	12	Sequence 21 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11275	RKKKKKIIKKLI	12	Sequence 22 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11276	KKKKKKIIKKII	12	Sequence 23 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11277	RKRAARLLKRLV	12	Sequence 24 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11278	RKRFARFAKRAV	12	Sequence 25 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11279	KKKAARALKRAL	12	Sequence 26 from Patent US 20110294722	Synthetic construct	Antimicrobial	US 2011/0294722 A1	Patent Application	2011##12##1	"EP2168976A1, EP2342213A1, WO2010034784A1"	Antimicrobial peptides.	"The present invention relates to a peptide comprising or consisting of a sequence of the formula A-B-C-D-E-F (formula I), wherein A is a peptide consisting of three to six basic amino acid residues; B is an amino acid residue or a peptide consisting of two amino acid residues, wherein said residue(s) are hydrophobic amino acid residues; C is a basic amino acid residue or is absent; D is a peptide consisting of two hydrophobic amino acid residues or is absent; E is a peptide consisting of two basic amino acid residues; and F is a peptide consisting of two hydrophobic amino acid residues; or a peptidomimetic thereof; wherein the basic amino acid residue is selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residue is selected from the group consisting of leucine, alanine, valine, phenylalanine, isoleucine and methionine; and wherein said peptide or peptidomimetic has antimicrobial activity. Furthermore, the invention relates to a nucleic acid mol"
DRAMP11280	KFKRWLA	7	Sequence 1 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11281	KFRAWVR	7	Sequence 3 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11282	KWKIWLK	7	Sequence 5 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11283	KKWRAWLKWLAKK	13	Sequence 7 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11284	KKWRKWLRAIAKK	13	Sequence 9 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11285	KKFRRFVRFIAKK	13	Sequence 11 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11286	KKWRRWLKWLAKK	13	Sequence 13 from Patent US 20110294724	Synthetic construct	Antimicrobial	US 2011/0294724 A1	Patent Application	2011##12##1	Unknown	"Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof."	"Disclosed is an antimicrobial peptide having an amino acid sequence of formula presented as (P1)M(nA1X1X2)N(P2)X, wherein P1 is selected from the group consisting of basic amino acids including Arg and Lys; A1 is selected from the group consisting of aromatic amino acids including Trp, Phe and Ala; X1 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; X2 is selected from the group consisting of basic amino acids or nonpolar amino acids, including Arg, Lys, Val, Leu, Ala and Ile; P2 is selected from the group consisting of basic amino acids including Arg and Lys; and the numbers of M and X are respectively 0??2; when N>2, A1 is Ala and the Ala residues are less than N??¡¯2."
DRAMP11287	RCICGRGICRCICGRGIC	18	Sequence 11 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11288	RCICGKGICRCICGRGIC	18	Sequence 12 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11289	RCICGKGICRCICGKGIC	18	Sequence 13 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11290	RGGRLCYCRRRFCVCVGR	18	Sequence 14 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11291	RGGRLCYCRRRFCVCV	16	Sequence 15 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11292	RGGGLCYCRRRFCVCVGR	18	Sequence 16 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11293	RGGRLCYCRGWICFCVGR	18	Sequence 17 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11294	RGGRLCYCRPRFCVCVGR	18	Sequence 18 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11295	GICRCICGKGICRCICGR	18	Sequence 21 from Patent US 20110302675	Synthetic construct	Antimicrobial	US 2011/0302675 A1	Patent Application	2011##12##8	Unknown	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP18753	RCICRRGVC	9	Sequence 33 from Patent US 20090264344	Synthetic construct	"Antimicrobial, Antibacterial, Antiviral"	US 2009/0264344 A1	Patent Application	2009##10##22	"US7314858, US7718610, US20050272645, WO2006052637A1"	"Retrocyclins, antiviral and antimicrobial peptides."	"Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV1 retrovirus or other sexuallytransmitted pathogens."
DRAMP11297	GFCWYVCVYRNGVRVCYRRCN	21	Sequence 2 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11298	GACWYVCVYRNGVRVCYRRCN	21	Sequence 3 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11299	GFCAYVCVYRNGVRVCYRRCN	21	Sequence 4 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11300	GFCEYVCVYRNGVRVCYRRCN	21	Sequence 5 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11301	GFCGYVCVYRNGVRVCYRRCN	21	Sequence 6 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11302	GFCSYVCVYRNGVRVCYRRCN	21	Sequence 7 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11303	GFCTYVCVYRNGVRVCYRRCN	21	Sequence 8 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11304	GFCYYVCVYRNGVRVCYRRCN	21	Sequence 9 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11305	GFCWKVCVYRNGVRVCYRRCN	21	Sequence 10 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11306	GFCWNVCVYRNGVRVCYRRCN	21	Sequence 11 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11307	GFCWRVCVYRNGVRVCYRRCN	21	Sequence 12 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11308	GFCWYACVYRNGVRVCYRRCN	21	Sequence 13 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11309	GFCWYECVYRNGVRVCYRRCN	21	Sequence 14 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11310	GFCWYGCVYRNGVRVCYRRCN	21	Sequence 15 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11311	GFCWYLCVYRNGVRVCYRRCN	21	Sequence 16 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11312	GFCWYNCVYRNGVRVCYRRCN	21	Sequence 17 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11313	GFCWYRCVYRNGVRVCYRRCN	21	Sequence 18 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11314	GFCWYSCVYRNGVRVCYRRCN	21	Sequence 19 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11315	GFCWYWCVYRNGVRVCYRRCN	21	Sequence 20 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11316	GFCWYVCAYRNGVRVCYRRCN	21	Sequence 21 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11317	GFCWYVCGYRNGVRVCYRRCN	21	Sequence 22 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11318	GFCWYVCHYRNGVRVCYRRCN	21	Sequence 23 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11319	GFCWYVCSYRNGVRVCYRRCN	21	Sequence 24 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11320	GFCWYVCYYRNGVRVCYRRCN	21	Sequence 25 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11321	GFCWYVCVIRNGVRVCYRRCN	21	Sequence 26 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11322	GFCWYVCVKRNGVRVCYRRCN	21	Sequence 27 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11323	GFCWYVCVRRNGVRVCYRRCN	21	Sequence 28 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11324	GFCWYVCVYRNGARVCYRRCN	21	Sequence 29 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11325	GFCWYVCVYRNGGRVCYRRCN	21	Sequence 30 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11326	GFCWYVCVYRNGKRVCYRRCN	21	Sequence 31 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11327	GFCWYVCVYRNGLRVCYRRCN	21	Sequence 32 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11328	GFCWYVCVYRNGPRVCYRRCN	21	Sequence 33 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11329	GFCWYVCVYRNGQRVCYRRCN	21	Sequence 34 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11330	GFCWYVCVYRNGRRVCYRRCN	21	Sequence 35 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11331	GFCWYVCVYRNGSRVCYRRCN	21	Sequence 36 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11332	GFCWYVCVYRNGVRACYRRCN	21	Sequence 37 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11333	GFCWYVCVYRNGVRGCYRRCN	21	Sequence 38 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11334	GFCWYVCVYRNGVRHCYRRCN	21	Sequence 39 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11335	GFCWYVCVYRNGVRKCYRRCN	21	Sequence 40 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11336	GFCWYVCVYRNGVRNCYRRCN	21	Sequence 41 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11337	GFCWYVCVYRNGVRQCYRRCN	21	Sequence 42 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11338	GFCWYVCVYRNGVRRCYRRCN	21	Sequence 43 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11339	GFCWYVCVYRNGVRSCYRRCN	21	Sequence 44 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11340	GFCWYVCVYRNGVRTCYRRCN	21	Sequence 45 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11341	GFCWYVCVYRNGVRVCHRRCN	21	Sequence 46 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11342	GFCWYVCVYRNGVRVCKRRCN	21	Sequence 47 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11343	GFCWYVCVYRNGVRVCNRRCN	21	Sequence 48 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11344	GFCWYVCVYRNGVRVCRRRCN	21	Sequence 49 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11345	GFCWYVCVYRNGVRVCYRRCH	21	Sequence 50 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11346	GFCWYVCVYRNGVRVCYRRCK	21	Sequence 51 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11347	GFCWYVCVYRNGVRVCYRRCR	21	Sequence 52 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11348	GFCWYVCVYRNGVRVCYRRCS	21	Sequence 53 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11349	GFCWYVCVYRNGVRVCYRRCT	21	Sequence 54 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11350	RFCWYVCVYRNGVRVCYRRCR	21	Sequence 55 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11351	GFCFYVCVYRNGVRVCRRRCN	21	Sequence 56 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11352	GFCAHVCVYRNGVRVCYRRCN	21	Sequence 57 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11353	GFCARVCVYRNGVRVCYRRCN	21	Sequence 58 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11354	GFCFYVCVRRNGVRVCYRRCN	21	Sequence 59 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11355	GFCGHVCVYRNGVRVCYRRCN	21	Sequence 60 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11356	GFCGRVCVYRNGVRVCYRRCN	21	Sequence 61 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11357	GFCSYVCVYRNGVRACYRRCN	21	Sequence 62 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11358	GFCSRVCVYRNGVRVCYRRCN	21	Sequence 63 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11359	GFCYRVCVYRNGVRVCYRRCN	21	Sequence 64 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11360	GFCWFVCVYRNGVRQCYRRCN	21	Sequence 65 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11361	GFCWHVCVYRNGVRSCYRRCN	21	Sequence 66 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11362	GFCWHVCVYRNGVRVCRRRCN	21	Sequence 67 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11363	GFCWKVCVYRNGVRVCSRRCN	21	Sequence 68 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11364	GFCWNVCVYRNGVRSCYRRCN	21	Sequence 69 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11365	GFCWNVCVYRNGVRVCHRRCN	21	Sequence 70 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11366	GFCWRVCVYRNGVRPCYRRCN	21	Sequence 71 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11367	GFCWRACVYRNGVRVCYRRCN	21	Sequence 72 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11368	GFCWRVCGYRNGVRVCYRRCN	21	Sequence 73 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11369	GFCWRVCHYRNGVRVCYRRCN	21	Sequence 74 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11370	GFCWRVCSYRNGVRVCYRRCN	21	Sequence 75 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11371	GFCWRVCVYRNGVRVCHRRCN	21	Sequence 76 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11372	GFCWRVCVYRNGVRVCNRRCN	21	Sequence 77 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11373	GFCWSVCVYRNGVRSCYRRCN	21	Sequence 78 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11374	GFCWYACVYRNGARVCYRRCN	21	Sequence 79 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11375	GFCWYACVYRNGKRVCYRRCN	21	Sequence 80 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11376	GFCWYACVYRNGVRACYRRCN	21	Sequence 81 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11377	GFCWYACVYRNGVRVCHRRCN	21	Sequence 82 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11378	GFCWYMCGYRNGVRVCYRRCN	21	Sequence 83 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11379	GFCWYVCAYRNGVRACYRRCN	21	Sequence 84 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11380	GFCWYVCSYRNGKRVCYRRCN	21	Sequence 85 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11381	GFCWYVCVKRNGARVCYRRCN	21	Sequence 86 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11382	GFCWYVCVKRNGVRSCYRRCN	21	Sequence 87 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11383	GFCWYVCVYKNGVRSCYRRCN	21	Sequence 88 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11384	GFCWYVCVYKNGVRVCHRRCN	21	Sequence 89 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11385	GFCWYVCVYPNGGRVCYRRCN	21	Sequence 90 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11386	GFCWYVCVYRRGVRQCYRRCN	21	Sequence 91 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11387	GFCWYVCVYRNGARVCCRRCN	21	Sequence 92 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11388	GFCWYVCVYRNGGRKCYRRCN	21	Sequence 93 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11389	GFCWYVCVYRNGVRLCHRRCN	21	Sequence 94 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11390	AFCWNVCVYRNGVRVCHRRCN	21	Sequence 95 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11391	DFCWNVCVYRNGVRVCHRRCN	21	Sequence 96 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11392	FFCWNVCVYRNGVRVCHRRCN	21	Sequence 97 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11393	HFCWNVCVYRNGVRVCHRRCN	21	Sequence 98 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11394	IFCWNVCVYRNGVRVCHRRCN	21	Sequence 99 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11395	KFCWNVCVYRNGVRVCHRRCN	21	Sequence 100 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11396	MFCWNVCVYRNGVRVCHRRCN	21	Sequence 101 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11397	QFCWNVCVYRNGVRVCHRRCN	21	Sequence 102 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11398	RFCWNVCVYRNGVRVCHRRCN	21	Sequence 103 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11399	SFCWNVCVYRNGVRVCHRRCN	21	Sequence 104 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11400	TFCWNVCVYRNGVRVCHRRCN	21	Sequence 105 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11401	VFCWNVCVYRNGVRVCHRRCN	21	Sequence 106 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11402	WFCWNVCVYRNGVRVCHRRCN	21	Sequence 107 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11403	YFCWNVCVYRNGVRVCHRRCN	21	Sequence 108 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11404	GGCWNVCVYRNGVRVCHRRCN	21	Sequence 109 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11405	GHCWNVCVYRNGVRVCHRRCN	21	Sequence 110 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11406	GICWNVCVYRNGVRVCHRRCN	21	Sequence 111 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11407	GLCWNVCVYRNGVRVCHRRCN	21	Sequence 112 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11408	GMCWNVCVYRNGVRVCHRRCN	21	Sequence 113 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11409	GPCWNVCVYRNGVRVCHRRCN	21	Sequence 114 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11410	GVCWNVCVYRNGVRVCHRRCN	21	Sequence 115 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11411	GWCWNVCVYRNGVRVCHRRCN	21	Sequence 116 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11412	GYCWNVCVYRNGVRVCHRRCN	21	Sequence 117 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11413	GFLQYVCVYRNGVRVCHRRCN	21	Sequence 118 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11414	GFCAYACVKRNGVRVCYRRCN	21	Sequence 119 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11415	GFCAKVCVYRNGVRSCYRRCN	21	Sequence 120 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11416	GFCARVCVYRNGVRACYRRCN	21	Sequence 121 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11417	GFCARVCVYRNGVRSCYRRCN	21	Sequence 122 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11418	GFCARVCVYRNGVRTCYRRCN	21	Sequence 123 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11419	GFCARVCSYRNGVRVCYRRCN	21	Sequence 124 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11420	GFCARVCVKRNGVRVCYRRCN	21	Sequence 125 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11421	GFCAWVCVYRNGVRQCYRRCN	21	Sequence 126 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11422	GFCAYVCVRRNGVRSCYRRCN	21	Sequence 127 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11423	GFCFYVCAYRNGVRSCYRRCN	21	Sequence 128 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11424	GFCFHVCVYRNGVRSCYRRCN	21	Sequence 129 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11425	GFCFNVCVYRNGVRSCYRRCN	21	Sequence 130 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11426	GFCFNVCVYRNGVRVCHRRCN	21	Sequence 131 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11427	GFCFRVCVYRNGVRKCYRRCN	21	Sequence 132 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11428	GFCFRVCVYRNGVRQCYRRCN	21	Sequence 133 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11429	GFCFRVCVYRNGVRSCYRRCN	21	Sequence 134 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11430	GFCFRVCVYRNGVRVCHRRCN	21	Sequence 135 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11431	GFCFRVCVYRNGVRVCQRRCN	21	Sequence 136 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11432	GFCFYVCVKRNGVRVCHRRCN	21	Sequence 137 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11433	GFCGHVCVYRNGVRVCYRRCA	21	Sequence 138 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11434	GFCGHVCVYRNGVRVCYRRCK	21	Sequence 139 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11435	GFCGHVCVYRNGVRVCYRRCL	21	Sequence 140 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11436	GFCGHVCVYRNGVRVCYRRCM	21	Sequence 141 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11437	GFCGHVCVYRNGVRVCYRRCP	21	Sequence 142 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11438	GFCGHVCVYRNGVRVCYRRCR	21	Sequence 143 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11439	GFCGHVCVYRNGVRVCYRRCS	21	Sequence 144 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11440	GFCGHVCVYRNGVRVCYRRCY	21	Sequence 145 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11441	GFCGHVCVYRNGVRACYRRCN	21	Sequence 146 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11442	GFCGHVCVYRNGVRFCYRRCN	21	Sequence 147 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11443	GFCGHVCVYRNGVRGCYRRCN	21	Sequence 148 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11444	GFCGHVCVYRNGVRHCYRRCN	21	Sequence 149 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11445	GFCGHVCVYRNGVRICYRRCN	21	Sequence 150 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11446	GFCGHVCVYRNGVRLCYRRCN	21	Sequence 151 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11447	GFCGHVCVYRNGVRMCYRRCN	21	Sequence 152 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11448	GFCGHVCVYRNGVRNCYRRCN	21	Sequence 153 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11449	GFCGHVCVYRNGVRQCYRRCN	21	Sequence 154 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11450	GFCGHVCVYRNGVRRCYRRCN	21	Sequence 155 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11451	GFCGHVCVYRNGVRSCYRRCN	21	Sequence 156 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11452	GFCGHVCVYRNGVRTCYRRCN	21	Sequence 157 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11453	GFCGHVCVYRNGVRWCYRRCN	21	Sequence 158 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11454	GFCGHVCVYRNGVRYCYRRCN	21	Sequence 159 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11455	GFCGHVCVYRNGVRVCFRRCN	21	Sequence 160 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11456	GFCGHVCVYRNGVRVCGRRCN	21	Sequence 161 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11457	GFCGHVCVYRNGVRVCIRRCN	21	Sequence 162 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11458	GFCGHVCVYRNGVRVCLRRCN	21	Sequence 163 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11459	GFCGHVCVYRNGVRVCMRRCN	21	Sequence 164 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11460	GFCGHVCVYRNGVRVCTRRCN	21	Sequence 165 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11461	GFCGHVCVYRNGVRVCVRRCN	21	Sequence 166 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11462	GFCGHVCVYRNGVRVCWRRCN	21	Sequence 167 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11463	GFCGKVCVYRNGVRHCYRRCN	21	Sequence 168 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11464	GFCGRVCVYRNGVRLCYRRCN	21	Sequence 169 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11465	GFCGRVCVYRNGVRRCYRRCN	21	Sequence 170 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11466	GFCGRVCVYRNGVRTCYRRCN	21	Sequence 171 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11467	GFCGRVCVRRNGVRVCYRRCN	21	Sequence 172 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11468	GFCGSVCVYRNGVRACYRRCN	21	Sequence 173 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11469	GFCGSVCVYRNGVRKCYRRCN	21	Sequence 174 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11470	GFCGSVCVYRNGVRRCYRRCN	21	Sequence 175 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11471	GFCGYVCVRRNGVRSCYRRCN	21	Sequence 176 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11472	GFCINVCVYRNGVRVCHRRCN	21	Sequence 177 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11473	GFCLHVCVYRNGVRQCYRRCN	21	Sequence 178 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11474	GFCLKVCVYRNGVRKCYRRCN	21	Sequence 179 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11475	GFCLRVCVYRNGVRQCYRRCN	21	Sequence 180 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11476	GFCLRVCVYRNGVRSCYRRCN	21	Sequence 181 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11477	GFCMEVCVYRNGVRVCTRRCN	21	Sequence 182 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11478	GFCMHVCVYRNGVRSCYRRCN	21	Sequence 183 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11479	GFCMNVCVYRNGVRVCHRRCN	21	Sequence 184 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11480	GFCMRVCVYRNGVRTCYRRCN	21	Sequence 185 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11481	GFCMSVCVYRNGVRQCYRRCN	21	Sequence 186 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11482	GFCMSVCVYRNGVRRCYRRCN	21	Sequence 187 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11483	GFCNRVCVYRNGVRICYRRCN	21	Sequence 188 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11484	GFCSKVCVYRNGVRRCYRRCN	21	Sequence 189 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11485	GFCSRVCVYRNGVRICYRRCN	21	Sequence 190 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11486	GFCTNVCVYRNGVRACYRRCN	21	Sequence 191 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11487	GFCTRVCVYRNGVRRCYRRCN	21	Sequence 192 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11488	GFCTRVCVYRNGVRTCYRRCN	21	Sequence 193 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11489	GFCTSVCVYRNGVRHCYRRCN	21	Sequence 194 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11490	GFCTYVCVKRNGVRKCYRRCN	21	Sequence 195 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11491	GFCVHVCVYRNGVRPCYRRCN	21	Sequence 196 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11492	GFCVHVCVYRNGVRVCHRRCN	21	Sequence 197 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11493	GFCVKVCVYRNGVRQCYRRCN	21	Sequence 198 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11494	GFCVNVCVYRNGVRVCHRRCN	21	Sequence 199 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11495	GFCVRVCVYRNGVRGCYRRCN	21	Sequence 200 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11496	GFCVRVCVYRNGVRPCYRRCN	21	Sequence 201 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11497	GFCVRVCVYRNGVRQCYRRCN	21	Sequence 202 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11498	GFCVRVCVYRNGVRRCYRRCN	21	Sequence 203 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11499	GFCVRVCVYRNGVRTCYRRCN	21	Sequence 204 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11500	GFCYHVCVYRNGVRYCYRRCN	21	Sequence 205 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as well. The chloroplast expressed peptides are useful to delay, prevent or treat viral and bacterial infections."
DRAMP11501	GFCYKVCVYRNGVRSCYRRCN	21	Sequence 206 from Patent US 20110306750	Synthetic construct	Antimicrobial	US 2011/0306750 A1	Patent Application	2011##12##15	"CN103068840A, WO2011154525A1"	Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts.	"Disclosed herein are antimicrobial compositions containing one or more antimicrobial peptides having been expressed in chloroplasts. Exemplified herein are the expression and use of retrocylin and protegrin. Disclosed herein are methods of engineering chloroplasts to express such antimicrobial peptides such that they are properly processed and active. Plants containing such chloroplasts are disclosed as w